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Abstract 
Helicobacter pylori (H. pylori) is a stomach bacterium that, while asymptomatic in most 
people, can cause a cascade of gastric pathology leading to the development of gastric cancer. 
For this reason, it has been categorized as a class 1 carcinogen. When outside the human 
stomach, H. pylori undergoes a morphological and metabolic change, transitioning into a viable 
but nonculturable (VBNC) state. This transition has made it challenging to characterize 
transmission and the infection risk associated with different routes of H. pylori exposure.  
In 1991 in Lima, Peru, researchers first associated H. pylori infection with water source. 
Since then, H. pylori has been associated with lack of access to clean drinking water and 
sanitation, and the bacterium has been identified in drinking water sources. Working together 
with Peruvian stakeholders and scientists at the University of Michigan, this dissertation aims to 
provide information that will help better characterize the risk posed by waterborne H. pylori. 
Thus, the overarching hypothesis of my dissertation is that water can act as a reservoir for H. 
pylori.  
In Chapter 1, we conducted an exposure assessment, quantifying the extent to which 
citizens of Lima are exposed to H. pylori via drinking water. After collecting water from a single 
location in Lima for one year, we examined the frequency and quantity of H. pylori found over 
that time. We show that drinking water in Lima is consistently contaminated with H. pylori, 
without any patterns related to seasonality.  
 In Chapter 2, we developed a mouse model to estimate the infectious dose of H. pylori in 
drinking water. As proof of principle, we exposed mice to drinking water contaminated with 
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viable, culturable H. pylori strain SS1 (a strain the is known to colonize mice effectively) in 
various doses over 4 weeks. We found a clear dose-response relationship: higher doses of H. 
pylori in drinking water cause higher incidence of infection, showing that H. pylori in water 
could be infectious. To gauge the infectivity of the VBNC form, we exposed mice to various 
exposure scenarios of VBNC H. pylori in drinking water, with ingested doses ranging from 1E6 
to 2.1E9 VBNC cells. To our surprise, none of the mice were infected. This suggests that strains 
of H. pylori may have variability in infectivity between their viable, culturable and their VBNC 
form. It also suggests that VBNC H. pylori in water may not contribute heavily to the overall 
burden of H. pylori infection seen globally.  
In Chapter 3, we examined two different strategies to control H. pylori infection in Lima. 
First, we investigated primary antibiotic resistance of H. pylori isolates from a clinical setting in 
Lima and the success rate of antibiotic therapy for treating H. pylori infection in Lima. We found 
that antibiotic resistance to first-line antibiotics amoxicillin and clarithromycin was fairly high 
(29.7% and 35%, respectively), but that resistance to the second-line antibiotic tetracycline was 
very low (3%). We also showed that the success rate of antibiotic therapy 6-8 weeks after the 
initial therapy was 65% - substantially lower than the standard 80-90% success rate hoped for 
with H. pylori infection. This suggests that while antibiotic therapy is still a viable treatment plan 
in Lima, more targeted treatment strategies (e.g. testing the antibiotic resistance profile of the 
infecting strain before treatment) for individuals with H. pylori infection could result in better 
clinical outcomes. Secondly, we tested the H. pylori reduction capacities of bleach disinfection 
and boiling water. We exposed culturable H. pylori to bleach for 5, 15, or 30 minutes, or brought 
water inoculated with H. pylori to a boil for 0, 1, or 5 minutes. We found that both bleach and 
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boiling disinfection results in total loss of culturability in H. pylori in water. This suggests that 
both water treatment options are likely useful for eradicating H. pylori in drinking water. 
This research helps shed light on several knowledge gaps. First, in the longest sampling 
campaign conducted to date, we show that water in Lima is consistently contaminated with H. 
pylori. Second, we proved that H. pylori in drinking water can be infectious in mice. Third, we 
highlight the differences in infectivity between the VBNC and culturable forms of H. pylori, 
which may cast doubts on the importance of drinking water as a primary source of H. pylori 
infection. Fourth, we show that antibiotic resistance among H. pylori is high in Lima, Peru, and 
provided the most thorough characterization of antibiotic resistance in Lima in the published 
literature. Fifth, we show that boiling and bleach disinfection may be effective water treatment 
strategies for waterborne H. pylori.  
Our exposure assessment is congruent with the hypothesis that H. pylori can be 
transmitted in water, but a better understanding of the population dynamics of H. pylori in water 
is necessary to characterize the risk of infection. Given that H. pylori typically exists in the 
VBNC form in water, our mouse data cast doubt on the importance of water as a reservoir of 
infection. However, more studies are needed that both examine the infectiousness of multiple 
strains of H. pylori as well as characterize factors – such as pH, the presence of other pathogens 
– that contribute to more or less efficient infection. With regards to infection control, given the 
uncertainty associated with H. pylori transmission in water, focusing on better and more targeted 
treatment of infection is a more important in the short term. More research is needed to evaluate 
the importance of preventing H. pylori transmission via water treatment. 
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Chapter 1  : Introduction 
 
Helicobacter pylori, a gram-negative spiral bacillus bacterium that colonizes the human stomach, 
has been a mysterious microbiological mover and shaker since its discovery. First isolated in the 
1980s, H. pylori overturned the idea that the stomach was sterile 1. Soon after, Robin Warren and 
Barry Marshall identified H. pylori in the stomachs of patients with active gastritis and peptic 
ulcer 1, and Barry Marshall showed that H. pylori could cause gastritis by drinking a live culture 
of the bacterium 2. Following this self-experimentation, research in the field has expanded 
rapidly, and H. pylori has now been consistently linked to peptic ulcer disease and categorized as 
a class 1 carcinogen, causing ~90% of the nearly 720,000 deaths each year from gastric cancer 
3,4. Infection with H. pylori is associated with a 3- to 6-fold increased risk of gastric cancer 5, 
though this burden falls unevenly upon low- and middle-income nations (such as Peru), where 
the rates of H. pylori infection are higher 6. Indeed, while an estimated 50% of the world’s 
population harbors H. pylori, only 20-30% of people in high-income nations carry the bacterium 
compared with up to 90% of people in low- and middle-income nations 6–9.  
 
As ever, though, the picture is more complicated than a simple “H. pylori bad” paradigm. Only 
10-20% of people who are infected with H. pylori ever develop negative symptoms 5, and early-
life H. pylori infection is associated with protective effects against asthma and allergies, as well 
as against esophageal cancer later in life 10–12. The mechanistic underpinnings of this protective 
effect have begun to be supported by animal studies 13–15. To further complicate the picture, H. 
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pylori is difficult to isolate from the environment. When outside the human stomach, H. pylori 
typically changes morphology from spiral bacillus to a coccoid form. When in this coccoid state, 
H. pylori is challenging to culture, though multiple studies have shown that coccoid H. pylori is 
membrane-intact 16, metabolically active, and, in mouse studies, infectious in very high doses 17–
19.  
 
The dominant route of H. pylori transmission is unclear. Epidemiologically, H. pylori infection is 
associated with low socioeconomic status (SES) crowded living conditions, and a lack of access 
to clean water and sanitation – especially in childhood 7,9,20. Children with an infected sibling 
have a higher likelihood of becoming infected themselves 21,22. H. pylori DNA has been found in 
multiple bodily areas and excretions, including saliva, dental plaques, the mouth, tonsils, 
esophagus, vomit, and feces suggesting the possibility of an oral-oral or fecal-oral route 7,9,23–26. 
The presence of H. pylori in excreta also points to the possibility of indirect transmission, 
including through fecal-contaminated reservoirs such as food and water 7. In this dissertation, the 
focus is on water as a potential transmission route in Peru, where gastric cancer is the leading 
cancer killer in men and women combined 27, and where there is a special interest in H. pylori 
contamination of water.  
 
This dissertation encompasses work that is a part of an existing collaborative project that began 
in 2010 between clinicians and public health officials in Peru and scientists and clinicians at the 
University of Michigan. This projects falls under the paradigm of an integrated assessment (IA) - 
an interdisciplinary project that brings together perspectives from government, communities, and 
industry to address a common goal 28: in this case, to better understand the role of contaminated 
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water as it relates to H. pylori in Lima, Peru. There has been dynamic interplay between the 
technical teams. consisting of scientists and physicians at the University of Michigan and the 
stakeholders, consisting of public health officials at the Peruvian Ministry of Health and local 
scientists and clinicians in Lima, Peru. The teams work together to collect and analyze data, and 
evaluate options that can be used to inform decision making (Figure 1). Because of the unique 
stakeholder perspective, this framework provides responsive feedback to researchers, who can 
then incorporate that feedback into the next sampling campaigns and planned experiments.   
 
Clinicians, scientists, and public health officials in Peru have been interested in water as a 
potential source of H. pylori infection since 1991, when Klein et al associated H. pylori infection 
with the source of drinking water 30. Conducted in Lima, Peru, this study linked H. pylori 
infection with the source of drinking water. After adjusting for SES, age, weight, and other 
demographic information, children with an external water source had ~3 times higher odds of 
infection than those with an internal water source, and that children from high SES families were 
11.4 times more likely to be infected if they consumed municipal tap water rather than private 
well-water. Since that time, additional studies have supported this finding. In a cross-sectional 
study in Kazakhstan, Nurgaviela et al found that individuals drinking river water had a 13.6 
times higher odds of H. pylori infection than those who did not 31, and Baker et al linked 
contaminated private well-water with higher likelihood of H. pylori infection in individuals in 
Pennsylvania 32. In a large study of 1,852 people in six Latin American countries, Porras et al 
found higher odds (OR: 1.3, 95% CI 1.0-1.8) of H. pylori infection in those lacking indoor 
plumbing 33. In Malaysia, Lee et al found that univariate associations between drinking well 
water, as well as certain unsanitary practices (including using pit latrines and not washing hands 
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before eating or after using the toilet) with H. pylori infection 34, but did not run further models 
to see how these associations were affected by adjusting for co-variates. None of these studies 
had a full medical history of individuals, however, and it is possible that infected individuals had 
acquired H. pylori from an infected family member or an outside reservoir of infection. While 
these studies do not show causality, they remain suggestive, especially considering the large 
body of evidence suggesting that H. pylori is present and viable in water.  
 
H. pylori can survive in water distribution systems and biofilms – extra-cellular proteinaceous 
structures that can protect bacteria from external stressors 35–37. Biofilms also present a potential 
mechanism through which H. pylori can be consistently present in water, as cells may grow in 
and subsequently shed from biofilms into water. H. pylori has now been identified in various 
aquatic environments (drinking water, well water, wastewater, river water, and marine water) 
through DNA-based culture-independent methods, including PCR and quantitative PCR (qPCR) 
32,38–45. These methods can detect and quantify the amount of H. pylori DNA in water, though 
they cannot determine the viability of the DNA’s source. Other culture-independent methods 
include microscopy techniques, such as fluorescent in-situ hybridization 16,39,46, which can 
determine whether H. pylori cells have intact membranes and are viable. Recently, several 
investigators have developed novel methods to culture H. pylori from previously inaccessible 
environments: from drinking water 39,47,48, wastewater 49,50, and a co-habitation with the marine 
copepod Tigriopus fulvus 51, though these studies have not yet produced a standardized method 
for isolating H. pylori from the environment. While these culture-based techniques provide 
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definitive proof that H. pylori is present and viable in these environments, they do not provide 
insight into how common H. pylori is in water, nor to the infection risk it poses.  
 
It remains unknown whether the presence of H. pylori in water reflects a high proportion of 
infection and shedding in the population, or whether it is due to a true infectious risk. A recent 
quantitative microbial risk assessment (QMRA) assessed the potential for a drinking water 
guideline for H. pylori 52, but the input data were quite limited. At that time, there were no 
quantitative reports of drinking water contamination with H. pylori, so the authors had to 
estimate exposure based on measures of H. pylori in surface and recreational water 43,44. Further, 
while there were two reports in the literature relating ingested dose to infection, both studies 
were conducted using the viable, culturable state of H. pylori (in the spiral bacillus form), and 
neither of them was performed in the matrix of drinking water 53,54. Though some studies have 
investigated the infectivity of the VBNC form, they were done using gavage – a technique that 
directly inoculates the stomach with a large bolus of bacteria – and thus are not representative of 
drinking water exposure. Further, no studies have examined the infectious dose of viable, 
culturable or VBNC H. pylori in water, so it is unknown whether these forms are equally 
infectious in this exposure route. Finally, there is a paucity of evidence about the effectiveness of 
point-of-use water treatment options for removing or eradicating H. pylori, though some studies 
have shown that it may remain viable after exposure to chlorine in drinking water 35,46. 
 
With these gaps in the literature and the historical context of gastric cancer being the leading 
cause of cancer mortality among men and women combined in Peru, there has been an interest 
and a pressing public health need to better understand how H. pylori transmitted and whether 
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treatment options (both clinically and environmentally) are effective for controlling the spread of 
H. pylori infection. The epidemiological associations and findings of H. pylori in water suggest 
that contaminated water could be a reservoir for infection. Thus, the overarching hypothesis of 
this dissertation is that drinking water may act as a reservoir for H. pylori infection. The 
objective was to collect data under the integrated assessment approach to ultimately provide data 
driven advice to policy makers in Lima, Peru.  
 
In the first aim, we conducted an exposure assessment of the H. pylori in drinking water in Lima, 
Peru, examining both the presence/absence and quantity of H. pylori found, as well as water 
characteristics (e.g. pH and temperature) that may contribute to water contamination with H. 
pylori. In the second aim, we investigated the infectiousness of H. pylori in drinking water using 
mice as a model organisms, examining the infectivity of both the viable, culturable form and the 
viable but non-culturable form of H. pylori. In the third aim, we evaluated two control 
approaches for H. pylori infection. First, we assessed the success of antibiotic treatment for H. 
pylori infection, and determined primary antibiotic resistance profiles among clinical isolates of 
H. pylori. Second, we evaluated the H. pylori eradication capacities of inexpensive water 
treatment options (bleach and boiling water) available in Peru.  
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Chapter 2  : Examination of Drinking Water Contamination with Helicobacter 
pylori in Lima, Peru 
 
 
Chapter 2.1: An Assessment of Drinking Water Contamination with Helicobacter pylori 
in Lima, Peru 
Introduction: Helicobacter pylori (H. pylori) is a stomach bacterium that, while asymptomatic 
in most people, can cause a cascade of gastric pathology leading to the development of gastric 
adenocarcinoma 1,2. For this reason, it is categorized as a class 1 carcinogen 1,3. H. pylori 
infection is hypothesized to be transmitted directly through fecal-oral, oral-oral, or gastro-oral 
routes, or indirectly through reservoirs, including food and water. In 1991, Klein et al. found 
higher odds of H. pylori infection among study participants in Lima, Peru with municipal 
drinking water compared to those using private wells 4. Since that time, lack of access to clean 
drinking water and proper sanitation has been identified in epidemiological studies as a risk 
factor for H. pylori infection 5–13. H. pylori rapidly changes morphology from a spiral bacillus to 
a coccoid form in water, entering a viable-but-not-culturable (VBNC) state that makes it 
challenging to culture 14–16.  
Recently, however, five independent studies have isolated and cultured H. pylori in 
wastewater and drinking water 17–21. In addition, H. pylori has been reliably detected in 
recreational and drinking water using molecular biology techniques such as PCR and fluorescent 
in-situ hybridization 4,14,15,22–24, and can survive in water distribution systems, likely through 
protection from biofilms 25,26. Finally, the VBNC form of H. pylori has been shown to be 
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infectious in mice via gavage 27,28, and we previously showed that waterborne H. pylori is 
infectious in mice 29.  
While it is plausible that water contaminated by H. pylori is a route for the transmission 
of H. pylori infection, the quantities of H. pylori found in drinking water (and thus the risk of 
infection from such sources) remain poorly characterized. Existing studies have measured the 
quantities of H. pylori in wastewater 23, surface water 30, and recreational water 31, and several 
studies have measured the presence/absence of H. pylori in drinking water using PCR 4,21,32,33. To 
our knowledge, only two studies have quantitatively measured H. pylori in municipal drinking 
water: one by our group in Lima, Peru 24, and the other in Spain 34. Both studies had limited 
sample sizes (n=87 and n=24, respectively), and were conducted in a variety of locations. In 
Peru, the highest quantity of H. pylori found in drinking water was 1.6E6 genome copies/L 24, 
while in Spain, it was 1.59E3 genome copies/mL 34.  
Our goal in this study was to better characterize the quantities and variation of H. pylori 
in drinking water over time, so we conducted a quantitative assessment of H. pylori in water in 
Lima, Peru, both cross-sectionally from several wells as well as repeated sampling from a single 
sink in the Lince district. We hypothesized that drinking water in Lima was contaminated with 
H. pylori, and that the quantities of H. pylori would vary seasonally. 
Materials and Methods 
Locations and sample numbers 
Three separate water sampling studies were conducted in Lima, Peru. First, in 2013, five water 
samples were collected from wells, which are used to supplement the drinking water supply 
downstream of the municipal treatment plant. These wells were located in the districts of Surco, 
El Agustino, Puente Piedra, and Comas. Second, 17 drinking water samples were collected 
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between June 19th and July 18th of 2014 from a single sink in the Lince district in Lima. Samples 
were collected once to twice per week, except during the week of June 30th-July 4th, when 
samples were collected twice per day from Monday-Friday. Finally, 241 total drinking water 
samples were collected once a day, five days per week from a single sink in the Lince district in 
Lima from June 2015 through the end of May 2016.  
 
Water sample collection  
Sterile bottles with sodium thiosulfate were prepared prior to sampling. 1L aliquots of drinking 
water were collected from the faucet after allowing the water to run for at least one minute, and 
then concentrated by vacuum filtration onto 0.22µM filter membranes 24. Water quality 
parameters including pH, temperature, and conductivity were monitored, and free available 
chlorine was measured using DPD among samples collected from June 2015-May 2016. Samples 
were handled per the US Geological Society guidelines 35. All membranes were stored at -80°C 
until processing and analysis at the University of Michigan.  
 
DNA extraction from membranes 
Well-water and drinking water samples from 2014: Membranes were thoroughly scraped in 1x 
PBS (0.2% Tween 20). After scraping, the eluant was transferred to a 1.5mL tube and 
centrifuged for 5 minutes at 16,000g. The supernatant was removed, and DNA was extracted 
from the resulting pellet using the QiaAMP DNA Mini Kit (Qiagen, Hilden, Germany) per the 
manufacturer’s instructions. DNA was eluted in 100uL of buffer AE.   
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Time-series sampling from June 2015- May 2016: The following phenol chloroform protocol for 
DNA extraction was adapted from Holinger et al. 2014 36. Each 0.22 µM filter (EMD Millapore, 
Ontario, Canada) was cut into >20 pieces using sterilized scissors, and placed into 2mL tubes 
holding ~0.5 g of 0.1 mm silica/zirconium beads (Biospec Products, OK, USA), 500 µL of 
phenol/chloroform/isoamyl (25:24:1) and 500 µL of lysis buffer (75mM NaCl, 75 mM TRIS pH 
8.0, 7.5mM EDTA, 2.85% SDS).  Samples were mechanically bead beaten for 2.5 minutes at 
high speed to separate cells from the membrane and lyse the cells. To separate phases, tubes 
were centrifuged for 7 minutes at 16,000g. Following centrifugation, ~450 µL of aqueous phase 
was transferred to a new 1.5 mL tube. 10 µL of glycogen (10 mg/mL), 200 µL of 7.5M-
ammonium acetate and 650 µL of isopropanol were then added to precipitate the DNA. The 
samples were then centrifuged for 25 minutes at 16,000x g to pellet the DNA. Afterwards, the 
supernatant was removed, and pellets were washed with 1 mL of cold 70% ethanol. The samples 
were then inverted 15-30 times and centrifuged for 10 minutes at 16,000x g. After removal of 
ethanol, the pellets were dried at 35°C for 1-2 hours using a vacuum spinner. DNA Pellets were 
suspended in 40 µL of 10mM TRIS with 1mM EDTA, pH 8.0. Following DNA extraction, 
samples were purified by washing in 1mL of 4°C 70% ethanol and 10 µL of 3M-sodium acetate. 
After inverting the sample tubes 15-30 times, they were centrifuged for 10 min at 16,000x g. 
Ethanol was removed, and pellets were dried at 35°C for 1-2 hours using a vacuum spinner. 
Pellets were again suspended in 40 µL of 10mM TRIS and 1mM EDTA, pH 8.0. 
 
qPCR (quantitative polymerase chain reaction)  
qPCR was performed on extracted DNA using a highly sensitive, previously established method 
37. Briefly, quantities of H. pylori in drinking water were quantified using a reaction mixture 
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containing 10 µL 2×SYBR GREEN PCR Master Mix (Applied Biosystems, Grand Island, NY, 
USA), 0.3 µL of each 20 µM primers HpA-F (ACTTTCTCGCTAGCTGGATGGTA) and HpA-
R (GCGAGCGTGGTGGCTTT), 8.9µL of sterile PCR water, and 0.5 µL of DNA template. 
Plates also included negative controls (no DNA added) and positive controls (H. pylori strain 
SS1 DNA), and a standard curve made with 0.5E1 to 5E5 genome copies of H. pylori strain SS1 
DNA. qPCR was run at the following conditions: 95°C for 10 minutes, 45 cycles of 95°C for 15 
seconds and 60°C for 1 minute, followed by a melting curve analysis, ramping from 60°C to 95°. 
Statistical analysis 
All statistical analyses were conducted in R Studio. Due to limited sample size, no statistical 
analyses other than descriptive statistics were examined among water samples from 2014 
(drinking water and well-water).  
The following statistical analyses were run only on samples from the June 2015-May 
2016 sampling period. Descriptive statistics were used to examine the distribution of H. pylori 
contamination, pH, temperature, conductivity, and free available chlorine. Time-series plots were 
constructed to examine potential seasonal patterns in water characteristics. 
Due the large number of negative samples (~80%), two models were run to account for 
zero-inflated data. The first was a logistic regression that modeled the presence/absence of H. 
pylori, based on all samples. The second was a linear regression modeling the quantity of H. 
pylori as an outcome, run on non-zero samples only. Put together, these regressions model the 
presence or absence of H. pylori in the sample, and, conditional on being a positive sample, the 
quantity present. Both models were adjusted for all water characteristic co-variates. Since the 
data arise as a time series because sampling occurred from a single location over the course of 
one year, two approaches were used to account for the possibility of autocorrelation in the 
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samples (i.e., non-independence from day-to-day). First, the prior day’s presence/absence of H. 
pylori contamination was included as a predictor in both models. Second, the autocorrelative 
effects of date on the presence/absence of H. pylori was measured in the logistic regression by 
incorporating a smooth function of date of sample using the R ‘gam’ package. The smooth 
function adjusts for autocorrelation by modeling the potential long-term calendar trends in the 
presence/absence of H. pylori. Smoothing functions were also used to investigate potential non-
linearity in the effect of the remaining water characteristics on the presence of H. pylori.  
Model residuals were used to examine model fit and to identify potentially outlying 
values. The influence of extreme values was examined by removing these values from the model 
and examining the resulting robustness of the models. Due to the highly-skewed distribution of 
residuals, the quantities of H. pylori were log-transformed in the linear regression model.  
Results 
H. pylori in drinking water 
3/5 samples collected from wells and 9/17 drinking water samples collected in the summer of 
2014 showed contamination with H. pylori (Table 2.1). There was consistent contamination of 
drinking water with H. pylori throughout the sampling period from June 2015-May 2016. About 
20% of samples were positive (49/241), every month had at least one day with contaminated H. 
pylori, and the longest stretch of time without a positive sample was 25 days (Figure 2.1).   
Water characteristics  
There were some missing measurements in the water characteristics data due to lack of reagent 
or instrumentation on that sampling day. Temperature was measured in 240/241 samples, pH in 
238/241, conductivity in 232/241, and free available chlorine in 209/241.  The World Health 
Organization recommends that the free chlorine residual available in drinking water should be 
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between 0.2 and 0.5mg/L 38. 189 of 209 samples were at or below 0.5 mg/L and 17/209 samples 
were below the minimum recommended residual of 0.2mg/L of Free chlorine (Table 2.2). While 
there is no official standard for pH in drinking water, the EPA recommends that the pH of 
drinking water should be above 6.5 and below 8.5 to avoid corrosion. 96 of the 238 samples were 
below the minimum recommended guideline of 6.5 39. Temperatures ranged from 19.7-27.7°C, 
and conductivity ranged from 326-616 µS/cm.  
 
Associations between water characteristics and H. pylori  
We found a significant negative association between temperature and presence of H. 
pylori, regardless of the method of analysis. Accounting for date using a smoothing function and 
all other co-variates, we found that the log odds of the presence of H. pylori was 37% lower (ß=-
0.46, SE=0.18, p<0.05) per degree higher temperature (Table 2.3, 1a). When accounting for 
autocorrelation with the previous date (Table 2.3, 1b), the log odds of the presence of H. pylori 
was 21% lower per degree higher temperature (ß=-0.24, SE=0.13, p<0.1) (Table 3, 1b).  
Temperature remained statistically significant in the smoothed model, even when the most 
influential point was removed (p<0.05).  
In the log-transformed linear regression models incorporating only positive samples, we 
found a significant positive association between pH and the quantity of H. pylori and a 
marginally significant negative association between conductivity and quantity of H. pylori. The 
quantity of H. pylori was 139% higher for each unit higher in pH, and 0.62% lower per µS/cm 
higher of conductivity (ß=-0.0027, SE=0.0015, p<0.1). After removing the most influential data 
point, the quantity of H. pylori 95% higher for each unit higher in pH (ß=0.29, SE=0.14, p<0.1, 
Table 2.3, 2b).  
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We did not find a statistically significant association between calendar time (i.e., long-
term seasonal trends) and the presence of H. pylori (figure not shown). Similarly, we did not find 
association between the presence of H. pylori in a given sample and presence of H. pylori in the 
prior day’s sample.  
Discussion 
To our knowledge, this is the longest time-series sampling study of drinking water in Lima, Peru, 
as well as the most thorough examination of drinking water contamination with H. pylori in the 
scientific literature. Based on our sampling, it appears that drinking water in Lima is consistently 
contaminated with H. pylori about 20% of the time (49/241 positive samples), in both the 
drinking water collected in Lince and in the wells used to supplement the treated drinking water 
supply. Based on the null associations found between presence/absence of H. pylori and the prior 
day’s sample, there is no strong autocorrelation to indicate any seasonal trends, suggesting that 
contamination occurs randomly over time in this location.  
While we found statistically significant relationships between temperature and the 
presence/absence of H. pylori and between pH, conductivity, and the quantity of H. pylori, 
inference from our data is somewhat difficult. In a laboratory study, the optimal pH for H. pylori 
survival in water was found to be 5.8-6.9, but that doesn’t account for other relevant factors, such 
as co-exposure with chlorine 40. Adams et al. (2003) found that H. pylori goes into a VBNC state 
more quickly at higher temperatures 14. However, this study used microscopy rather than culture-
based methods, so could not comment on persistence or reproduction at these temperatures. The 
inconsistency of the relationship between temperature and H. pylori, as well as a lack of 
explanatory mechanism for how pH might be positively associated with the quantity of H. pylori 
makes it uncertain whether these relationships are meaningful. Thus, it seems likely that other, 
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unaccounted-for factors might be important to presence or quantity of H. pylori contamination, 
such as the frequency of infusions of well-water from contaminated wells, contamination from 
leaks in the distribution, and the stochastic shedding of cells from biofilms in the pipes.  
However, the fact remains that our investigation shows that there is consistent 
contamination of drinking water with H. pylori in Lima, Peru. Since 1996, there have been 
mixed reports of the presence of H. pylori in drinking water. Investigations in Peru 4,24, Sweden 
41, Pakistan 32, Iraq 17, Iran 20,42, Costa Rica 21, and Spain 34 showed contamination of drinking 
water with H. pylori using PCR, culture, and microscopy techniques such as fluorescent in-situ 
hybridization. Studies in Bangladesh 37 and Japan 33 failed to detect H. pylori in treated drinking 
water, though the study in Japan and a further study in Scandinavia detected H. pylori via PCR in 
untreated well-water being used as drinking water 6,33. The results from our study are consistent 
with those that found contamination, though the scope of our sampling, in terms of length of time 
and number of samples, was wider than any previously reported study. The quantities of H. 
pylori we found were also substantially lower than those reported in Spain and Peru, with our 
highest value being 2.5E3 genome copies/L, compared to 1.59 and 1.6E6 genome copies/L.  
Limitations 
Because we used a DNA-based method of detection, we could not determine between 
viable and non-viable H. pylori cells in drinking water, so we are unable to infer whether the 
DNA amplified was from culturable, viable but non-culturable, or non-viable H. pylori cells. 
Thus, examining our results in a risk assessment format would be problematic, as the relative 
infectiousness of the VBNC compared to the culturable form is not well characterized. However, 
Sen et al. (2011) found that H. pylori DNA cannot be amplified after exposure to chlorine in tap 
water for 2-3 days; a period of time that it typically takes for water to go from the treatment plant 
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to a household 43. This suggests that the DNA detected in our and other studies in chlorinated 
drinking water may have come from VBNC or viable, culturable H. pylori cells.  
Further, it is uncertain whether water in the Lince district is representative of water 
elsewhere in Lima. Based on our previous cross-sectional sampling through the city of Lima, 
there appeared to be a wide spread of contamination, though this did not appear to be linked to a 
specific district 24. Given that there are leaks in the distribution system and the large amount of 
unaccounted-for water 44, it is possible that some areas of Lima might have more contamination 
than others. Further studies are needed throughout the city to examine whether such 
contamination is systemic.  
Public Health Implications 
Other studies in the literature provide more of a snapshot of water contamination with H. pylori, 
collecting samples either once or a handful of times from multiple locations 6,24,34. By collecting 
water from a single location over a year, we better characterized the annual body burden of H. 
pylori from drinking water in Lima, which can be used to more accurately assess risk of infection 
from this exposure route.  
In the only quantitative microbial risk assessment performed thus far for H. pylori in 
drinking water, Ryan et al. (2014) recommended that the maximum contaminant level goal for 
H. pylori be set at <1 organism/L in drinking based on the downstream risk of infection and 
gastric cancer 47. That study used quantities of H. pylori found in surface and recreational water 
30,31, which, when accounting for the efficiency of municipal water treatment in the USA, were 
substantially lower than those found in our study. However, the dose-response used in that study 
was performed with viable, culturable cells administered via gavage rather than via drinking 
water. Our and other quantitative surveys of H. pylori contamination of drinking water cannot 
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distinguish between VBNC, viable culturable, and non-viable H. pylori cells. Thus, although 
several samples in our and other studies 24,34 had quantities of H. pylori found to be infectious in 
either mice, humans, or monkeys 29,45,46, it is unclear whether the sampled water poses the same 
infectious risk found in dosing trials since these trials used the viable, culturable state of H. 
pylori. Further dosing studies are needed to better characterize the infectivity of viable but non-
culturable H. pylori in drinking water to develop more accurate risk assessments. 
Finally, the contamination of finished water from La Atarjea 4,24 and the consistent 
contamination of well-water used to supplement the finished drinking water highlights the need 
for point of use water treatment options and long term investment in water treatment 
infrastructure to provide safe, potable water to the populace of Lima.  
Conclusions 
Over a three-year sampling period, we consistently detected H. pylori in drinking water from 
Lima, Peru using qPCR, suggesting that there is continued contamination of the water supply. 
More work is needed to identify the potential sources for contamination and better characterize 
the risk of H. pylori in drinking water, especially in distinguishing between viable, culturable and 
VBNC cells . Given that gastric cancer is the most common cause of cancer mortality in Peru, 
these findings highlight the need for effective point-of-use household water treatment in the short 
term, and long-term investment in infrastructure to provide high quality drinking water for the 
citizens of Lima, Peru.  
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Table 2.1: Distribution of H. pylori in drinking water samples from Lima, Peru. 
 Positive (n/N) Range of genome copies/L in 
positive samples (above detectable 
limit only) 
June 2015 – May 2016 49/241 4.12E2 – 2.56E3  
Summer 2014 9/17 8.8E2 – 1.95E4 
  Well-water samples: 2013 3/5 1.46E3 – 2.32E3 
Table 2.1. Distribution of H. pylori in drinking water samples from Lima, Peru. 
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Figure 2.1. Genome copies/Liter of H. pylori (A), pH (B), Conductivity (C), free chlorine residual (D), and Temperature (E) in 
drinking water collected from June 2015 through May 2016. A) The blue line represents the limit of detection for genome 
copies/L of H. pylori. B) The blue line represents the upper limit of the EPA secondary standard for pH (8.5), while the red line 
represents the lower secondary standard for pH (6.5). D) The upper line in the free chlorine residual graph represents the upper 
limit of the WHO recommendation for FAC (0.5) and the lower line represents the minimum recommended FAC residual. 
 
Table 2.2. Water characteristics from Jun 2015-May 2016 sampling campaign 
 N Range Median Mean Notes 
pH 238 5.16-8.43 6.68 6.54 96 samples below the EPA 




240 19.7-27.7 23.3 23.6 Fairly high temperatures, 
good conditions for bacterial 
growth 
Conductivity in  232 326-616 512 504.8  
Free chlorine 
residual in µS/cm 
209 0.01-0.78 0.37 0.3658 17/209 samples below 
WHO recommendation of 
0.2-0.5 mg/L of FAC 
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Table 2.2. Summary of water characteristics from sampling campaign in Lima from June 2015 through May 2016. Note: Not all 
water characteristics were measured in all samples due to lack of reagent or instrumentation on that sampling day. 
Table 2.3: Statistical models examining the relationship of pH, free available chlorine residual, 
conductivity, temperature, and the presence/absence or quantity of H. pylori. 





Model 1b: Logistic 
Regression - 
autocorrelation 











Intercept 9.73 (5.42) 5.41 (5.12) 0.29 (2.25) 1.54 (2.31) 
Prior day 
presence/absence 
of H. pylori  
N/A 0.27 (0.43) 0.03 (0.18) 0.034 (0.18) 
Cl2 residual -0.33 (1.6) -0.99 (1.58) 0.56 (0.67) 0.28 (0.67) 
pH 0.23 (0.33) -0.04 (0.31) 0.38 (0.14)** 0.29 (0.14)* 
Conductivity -0.003 (0.004) -0.001 (0.004) -0.0027 (0.0015)* -0.002 (0.0015) 
Temperature -0.46 (0.18) ** -0.24 (0.13)* 0.025 (0.57) -0.017 (0.06) 
Table 2.3. *=p<0.1, **=p<0.05, ^Influential outlying value removed. 
Chapter 2.2: Examination of drinking water from patient homes in Lima, Peru 
Note: The text below is excerpted from the results section of Appendix A due to its 
relevance to this chapter. For the full text, context, and discussion of the entire study from 
which these results were drawn, please refer to Appendix A.   
Cross-sectional investigation of water contamination with H. pylori from homes and the main 
municipal plant (La Atarjea) in Lima, Peru  
Forty-two of 87 filtered water specimens were positive by qPCR (48.3%), with median 931.5 
(range 8.5-1,682,500) CN/mg. Residual chlorine was measured in 80 of 83 filtered water 
samples (96.3%), with median 0.7 (range, 0.1-1.25) mg/L. 
 
The physical properties of the filtered drinking water specimens were as follows: median pH 7.0 
(range, 6.5-8.5); median conductivity 53.2 µmhos (microohms per centimeter; range, 40-939); 
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median Celsius temperature 22.6 (range, 18.8-27.4) and median turbidity 0.1 NTU 
(nephelometric turbidity unit; range, 0.0-27.4). 
 
Attempts to culture H. pylori from patient’s drinking water samples and from four samples taken 
from the main water plant in Lima (La Atarjea) were unsuccessful. However, all four La Atarjea 
samples, including two samples from the river intake (Rímac River) and two from two different 
reservoirs of treated water ready for public consumption, tested positive by qPCR: 1378.34, 




Chapter 3  : Dosing Studies with Waterborne Helicobacter pylori 
 
Chapter 3.1: Dosing Studies with the Viable, Culturable Form of Helicobacter pylori in 
Drinking Water.1  
Introduction: Helicobacter pylori (H. pylori) is a gut bacterium that, while asymptomatic in 
most people, can cause peptic ulcers and has been categorized as a class 1 carcinogen, causing 
gastric adenocarcinoma 1,2. H. pylori infection is hypothesized to be transmitted directly through 
fecal-oral, oral-oral, or gastro-oral routes, or indirectly through reservoirs, such as food and 
water 3,4. Since the landmark study by Klein et al in 1991 5, lack of access to clean drinking 
water and proper sanitation has been consistently identified in epidemiological studies as a risk 
factor for H. pylori infection 3–10. Moreover, H. pylori has been detected in water using 
molecular biology techniques such as PCR and fluorescent in-situ hybridization 11–14. When 
exposed to water, H. pylori rapidly enters a viable-but-not-culturable (VBNC) state 15–17. This 
change may be accompanied by a changed morphology (from spiral bacillus to a U-shaped or 
coccus form), although it survives in the VBNC state in all morphologies in the natural 
environment 16. Historically, this conversion to a VBNC state has made H. pylori difficult to 
culture, and has raised skepticism about whether H. pylori is viable and infectious in water. 
However, four independent studies have now isolated and cultured H. pylori in wastewater and 
drinking water using different methods 18–21. In spite of this evidence that viable H. pylori can be 
                                                
1 This chapter was previously published in the journal Helicobacter: Boehnke, K. F., Eaton, K. A., Valdivieso, M., 
Baker, L. H., & Xi, C. (2015). Animal model reveals potential waterborne transmission of helicobacter pylori 




isolated from drinking water, to our knowledge, there are still no studies demonstrating that 
drinking water contaminated with H. pylori can cause infection in humans or animals. In fact, a 
recent review by Aziz et al (2013) called for animal models to study the transmission of H. pylori 
in water 17.  
  
Mice are commonly used as a model animal to study different aspects of H. pylori 
infection, including development of gastric inflammation and genes related to successful host 
colonization 15,22. These studies typically use oral gavage to infect mice, directly inoculating their 
stomachs with doses ranging from 106-109 CFU of H. pylori. She et al. (2003) inoculated 16 
BALB/C mice over 12 days with 4 doses of ~4*108 CFU coccoid H. pylori by oral gavage 15. 
Following exposure, 11 of the 16 mice developed H. pylori infection, and culturable H. pylori 
was recovered from their stomachs (compared to 14 of 16 mice dosed with spiral H. pylori). This 
study supports our hypothesis that H. pylori can be infectious in the VNBC state and thus 
transmitted in drinking water. However, the doses in these studies were applied directly to the 
stomach via gavage, and were higher than those reported in surface water and wastewater, which 
range from 0-594 cells/mL 14,23,24. Thus, our goal was to develop a mouse model to demonstrate 
a dose-response relationship for transmission of H. pylori infection in drinking water.  
Previously, we conducted pilot studies demonstrating that high concentrations of H. 
pylori strain Sydney Strain 1 in drinking water can infect mice. We carried out two experiments: 
a one week exposure of Severe Combined Immunodeficient (SCID) C57/BL6 mice (001913 
from Jackson Labs) to 109 CFU/L of H. pylori and a two-week exposure of immunocompetent 
16 C57/BL6 mice (000664 Jackson Labs) to varying static concentrations of H. pylori (105, 107, 
109 CFU/L). These concentrations were chosen for three reasons: 1) the amount of H. pylori in 
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water would be consistent with the highest values found in the literature 23,24, 2) the actual dose 
in mice would be similar to the dose in humans, and 3) to include a ‘worst case’ scenario (109).  
The mice were allowed to drink ad libitum from water bottles containing sterilized de-ionized 
water contaminated with H. pylori. Their water was changed twice per week (Tuesday and 
Friday). After exposure, 5 of 5 SCID mice were infected, and 1 of the C57/BL6 mice exposed to 
109 CFU/L was infected (confirmed by quantitative culture and histology, unpublished data). 
Thus, for our current study, we decided to increase the sample size and the exposure period 
length, and to keep similar concentrations for consistency with our previous study. We chose 
four weeks as an exposure length since that was used in the only dosing experiment of H. pylori 
in humans 25. We hypothesized that mice exposed to variable concentrations of H. pylori in 
drinking water would display differing incidences of infection in a dose-dependent manner. 
 
 
Materials and Methods:  
Bacterial strain 
H. pylori is not a normal mouse inhabitant, and therefore, most strains of H. pylori colonize mice 
poorly. SS1 (Sydney Strain 1) was selected for this study since it colonizes mice more 
successfully than other H. pylori strains (with infectious doses as low as 200 CFU) 26, and thus 
would better mimic the success of H. pylori infecting humans 22.  
 
H. pylori cultivation, counting, and inoculation 
The SS1 strain was grown in microaerobic conditions at 37°C on 5% Sheep Blood Tryptic Soy 
Agar II plates (BBL). After 3 days of growth, colonies were collected and used to inoculate 
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Brucella broth (Remel) supplemented with 10% heat-inactivated fetal bovine serum (Fisher 
Scientific). After shaking overnight at 40 RPM in microaerobic conditions at 37°C, the broth was 
centrifuged for 20 minutes at 3500 RPM, 4°C to gently pellet the bacteria. The supernatant was 
removed, and the pellet was suspended in 1mL of 1x PBS. To estimate the total number of 
bacteria, 10 µL of the H. pylori suspension was added to 890 µL of 1x PBS and 100 µL of 
Buffered Formalin Phosphate. 10 µL of this solution was then pipetted onto a hemacytometer, 
covered with a cover slip, and cells counted at 40x magnification. Based on the hemacytometer 
estimate, sterilized water was inoculated with the appropriate amounts of H. pylori. To confirm 
the concentration of H. pylori in the water, the stock suspension was serially diluted onto 5% 
Sheep Blood Tryptic Soy Agar II plates (BBL). After 3 days of growth, the number of H. pylori 
colonies was counted and the stock solution concentration was back-calculated.  
 
H. pylori viability in water 
Sterilized water was inoculated in triplicate with 1010 CFU/L of H. pylori grown and counted 
using the method above. The water was stored at room temperature for 3 days. H. pylori in water 
was checked for culturability by quantitative plating on 5% Sheep Blood Tryptic Soy Agar II 
plates (BBL) 1 hour, 2 hours, 4 hours, 1 day, 2 days, and 3 days after inoculation. At these same 
time points, H. pylori cells were checked for viability and morphology using microscopy at 40x 
magnification and Live/Dead staining (BacLight). Briefly, 6mL of water was centrifuged at 
10,000 RPM for 3 minutes. The water was removed, and cell pellets were resuspended in 
BacLight Live/Dead dye. After incubating for 15 minutes in the dark, the cell suspensions were 
examined under a microscope using red and green fluorescence. Both live and dead cells were 
counted, and morphology of each cell type (spiral bacillus, coccus, or U- shape) was recorded. 
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Staining was used only to estimate the percentage of cells in each state, rather than to quantify 
cell number. 
 
Transmission and Exposure groups 
Fecal-oral transmission is posited as one of the main forms of H. pylori transmission [3, 4], and 
mice consume their own feces. Since the mice were H. pylori free, the only way that a mouse 
could be infected was through drinking infected water. However, once a mouse became infected, 
it would no longer be possible to determine whether other mice in the cage were infected from 
drinking contaminated water or from eating H. pylori contaminated feces. To account for this, 
each cage was used as an experimental unit rather than each mouse.  
 Groups of 4-week old C57/BL6 Helicobacter-free mice (Jackson Labs 000664, 
maximum barrier) were exposed to five different concentrations of H. pylori in sterilized, filtered 
tap water (1.29x105, 106, 107, 108, and 109 CFU/L) and uncontaminated sterilized, filtered tap 
water (negative control). We conducted two sets of exposures: the first set with positive and 
negative controls and the 105, 107, and 109 groups, and the second set with the 106 and 108 
groups. All procedures were carried out identically throughout both experiments. The drinking 
water was changed twice weekly and replaced with fresh water containing H. pylori. Each 
exposure group had 20 cages, with two mice per cage per the Animal Care and Use Committee 
regulations. The negative control group had 10 cages, with two mice per cage.  Unfortunately, 
one cage of 107 CFU/L mice perished in the first week of the experiment after a water bottle 
leaked, leaving only 19 cages in that exposure group. As a positive control, one cage of two 
C57/BL6 Helicobacter-free severe combined immunodeficient mice (Jackson Labs 001913) was 
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exposed to 109 CFU/L.  All mice were housed at ULAM facilities at the University of Michigan 
Medical School, and all experiments were approved by the Animal Care and Use Committee.   
 
Mouse sacrifice, verification and quantification infection 
After 28 days of exposure, the inoculated water was removed, and mice were given autoclaved 
filtered tap water without H. pylori. The negative control mice, 105, and 106 CFU/L mice were 
sacrificed 1 day after this final water change, and the 107, 108, and 109 CFU/L mice were 
sacrificed 2-3 days after the final water change. After sacrifice, mouse stomachs were collected. 
Two strips of stomach were cut from the greater curvature and fixed by immersion in 10% 
neutral buffered formalin.  Sections were then paraffin-embedded, cut in 5 micron sections, and 
stained with Warthin-Starry silver stain to detect the presence of H. pylori. Histologic scoring 
was performed as previously described 27.  Briefly, sections were examined in their entirety and 
the percent of the mucosa containing neutrophilic inflammation; mononuclear cell inflammation, 
and mucosal metaplasia was quantified.  The total score was the sum of the percentages in each 
lesion category. The remaining portion of the stomach was weighed, homogenized in 1x PBS, 
and serial dilutions of the homogenate were plated on H. pylori selective media (Columbia blood 
agar base with 10% horse blood, Dent Supplement, 300mg/L urea, and 3500U polymyxin B/L) 
28. Presumptive H. pylori isolates were counted and then checked for urease activity using a 
urease indicator broth (0.33M urea, 0.2% Phenol Red, 0.02% NaN3, 0.01M pH 6.5 NaPO4 
buffer). DNA was then extracted from presumptive colonies using the QiaAMP DNA Mini Kit 
(Qiagen). The extracted DNA was tested for the presence of the H. pylori 16s rRNA gene by 
PCR using the Takara PCR kit (Fisher, TAK RR001A) and primers HP1 
(5′GCAATCAGCGTCAGTAATGTTC3′) and HP2 (5′GCTAAGAGATCAGCCTATGTCC3′), 
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which are specific to the 16s rRNA gene of H. pylori [20]. For PCR, we used an initial 
denaturation at 95°C for 2 min, followed by 35 cycles of 94°C for 1 min, 56°C for 1 min, 72°C 
for 1 minute, and a final extension at 72°C for 7 minutes 20. PCR products were visualized on a 
1.5% agarose gel. 
 
Statistical methods 
To gauge the effect of waterborne concentration of H. pylori on infection rate and estimate a 
dose-response trend, a logistic regression model was constructed with infection status (of cages) 
as the outcome and waterborne concentration of H. pylori (log-transformed) as the predictor. 
Deviations from the linear relationships between log odds of infection and log concentration of 
waterborne H. pylori was investigated by fitting a model including a quadratic version of the log-
transformed concentration of H. pylori in water. Crude associations between predictors (sex, 
infection status, CFU/gram stomach tissue, log-transformed waterborne concentration) and 
gastric inflammation score (range 0-300%) were explored using mixed effects linear models 
taking into account cage effects were constructed. Since only infected mice had quantitative 
culture results greater than 0, models were also run on infected mice only. All analyses were run 
in SAS version 9.4. 
 
Based on our previous experiments, we expected that at least 80% of cages in the 109 group 
would be infected with H. pylori. With 20 exposure cages and 10 control cages, this would 
provide >80% power at α=0.05 significance level to detect differences in infection rates between 




Morphology and culturability of H. pylori in water 
Culturability of H. pylori dropped consistently at each time point, with a ~50% loss from 
baseline to hour 1, steady declines in culturability in hours 2 and 4, a log reduction from hour 4 
to day 1, and complete loss of culturability 2 days after initial exposure to water (figure 3.1). The 
results of the morphology experiment are summarized in figure 3.2. At baseline, about 90% of H. 
pylori cells were spiral bacillus. This percentage dropped fairly consistently over time after 
exposure to water, with a higher percentage of cells manifesting coccus or U-shape forms in later 
time points.  
  
Exposure to waterborne H. pylori 
A cage was counted as infected if the following conditions were met: the quantitative culture 
plates had colonies with correct H. pylori morphology (small, round, and translucent), were 
positive for the rapid urease test, and were positive for PCR targeting the 16s rRNA gene.  If one 
or both mice in a cage were infected, then we counted that cage as positive. If no mice were 
infected, then we counted that cage as negative. The results of the experiment are summarized in 
Table 3.1 and Figure 3.3. None of the cages of negative control or 105 mice (0/10 and 0/20, 
respectively) were infected with H. pylori. 1 of 20 cages of the 106 group (5%), 3 of 19 cages of 
the 107 group (15.7%), 19 of 20 of the 108 group cages, 20 of 20 of the 109 group cages had 
infected mice (100%), and 1 of 1 cages of the SCID mice (positive control) were infected with 
H. pylori. The quantities and range of H. pylori recovered from infected stomachs are shown in 
Table 3.2, and the evidence of H. pylori colonization is also shown via histology imaging in 
Figure 3.4. In the logistic regression model, the log odds of infection increased by 3.57 per 10-
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fold increase of waterborne H. pylori concentration (p>0.0001) (see Figure 3). Deviations from 
linearity were not significant (p=0.1021).  
 
Inflammation scoring 
The range of inflammation scores of infected mouse stomachs are found in Table 3.2. Crude 
associations in the complete data set showed significant increased relationships between 
inflammation and infection (27.86%, p<0.0001), and 10-fold increase in waterborne 
concentration of H. pylori (8.32, p=0.0003) (see Table 3.3). Interestingly, increasing waterborne 
concentration of H. pylori was also associated with a decrease CFU/gram tissue (4.48*106 fewer 
CFU/gram tissue per 10-fold increase in waterborne concentration of H. pylori). However, this 
last result is likely spurious, as the only 106 mouse to be infected had a relatively high quantity of 
infection and we did not have sufficient power to accurately gauge the effects of waterborne 
concentration of H. pylori on colonization density. Since only infected mice had positive 
quantitative culture results and infection status mediates the effect of waterborne concentration 
on inflammation, we stratified the data by infection status and ran our full model on the infected 
mice only. Among infected mice, we found that the effect of waterborne concentration is no 
longer significant (p=0.9572), suggesting that infection status was driving the previous 
association between waterborne concentration and inflammation. Interesting, among infected 
mice there was an associated decrease of -1.41 % in inflammation score (p=0.0055) per 106 CFU 




To our knowledge, this is the first published study demonstrating the transmission of H. pylori in 
drinking water. We found that contaminated drinking water can be a reservoir of H. pylori 
infection, lending credence to the epidemiological associations in the literature. We also showed 
that under the tested exposure conditions: 109 CFU/L is more than sufficient to infect mice, 105 
CFU/L is insufficient to infect mice, and that the minimum infectious concentration of H. pylori 
in water for this paradigm falls around 106 CFU/L.  
 Our results demonstrate that H. pylori infection via drinking water is possible, but much 
work remains to better characterize this relationship. For example, our successful infectious 
concentrations were refreshed twice weekly and were much higher than the concentrations of H. 
pylori described in naturally contaminated drinking water. While SS1 is well adapted to 
colonizing mice, H. pylori is not a normal mouse inhabitant, and the infectious dose in humans 
may be lower than for mice. We also did not determine the concentration of H. pylori in the mice 
feces using qPCR or other quantitative methods, so the average daily exposure may be higher 
than the amount in the water.  
 
Gastric Inflammation 
While crude associations suggested that waterborne concentration of H. pylori affected 
inflammation status, further analyses showed that this was likely due to the increased infection 
levels at increased concentrations of waterborne H. pylori. While we had insufficient power to 
accurately gauge this association, this suggests that once infection occurred, it likely progressed 
in a similar way in all infected animals. The association of increased infection density with 
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decreased inflammation was surprising, but consistent with other findings in the literature, 
suggests inflammation suppresses colonization, and that as inflammation is reduced, H. pylori 
continues to colonize more densely within already infected tissue 29. It is also possible that four 
weeks is simply not long enough to result in consistent gastric inflammation in infected mice 
[30]. 
 
Public Health Implications 
The minimum infectious dose for H. pylori in humans is not established.  A study by Graham et 
al found that humans given a single oral dose of 104-1010 CFU of H. pylori resulted in infection, 
but failed to determine a minimum infectious dose since the study participants at all doses got 
infected 25. Mice typically drink around 7mL of water per day 30, so mice in the infected groups 
consumed between ~7*103 CFU per day (106 group) and 7*106 CFU/day (109 group). These 
amounts (excepting the 109 group) are not dissimilar to those that humans would be consuming 
based on concentrations found in drinking and recreational water in the literature. However, the 
mice did not drink the daily amount in a single dose; rather, they drank that amount throughout 
an entire day, meaning that the minimum infectious dose could be smaller than the above 
numbers since each sip of water may have been the infectious dose. Our results show that H. 
pylori in water is infectious, and thus may be a risk to human health. A recent quantitative 
microbial risk assessment (QMRA) of H. pylori in water agreed, suggesting a Maximum 




As noted above, the concentrations to which we exposed mice were higher than those found in 
the environment 14,23,24, and likely do not accuracy reflect the environmental concentrations. 
Also, since we used sterilized, filtered tap water, we may be missing water characteristics that 
potentially aid or inhibit H. pylori infection and survival in water, for example lowered pH, 
presence/absence of other organisms, and presence of particulate matter or metals. Further, the 
water used in this study contained static concentrations of H. pylori, which does not reflect the 
reality of drinking water contamination, especially in places that lack water treatment like 
developing nations 32. Precipitation frequency and seasonal differences likely affect how much 
H. pylori is in the water through sources of contamination including sewage overflows and run-
off from farms.  Thus, we cannot make predictions as to the potential frequency of water-borne 
infection; only that it is possible. 
 
Future directions 
Continued mouse experiments could be done to start teasing out the importance of these 
variables by exposing mice to H. pylori-contaminated water for a single day (or other relevant 
periods of time). Changing the water characteristics to reflect those found in municipal or well 
water would make future studies more representative of actual drinking water conditions. 
Continued surveys of H. pylori in drinking and recreational water using quantitative techniques 
like qPCR could be done to better gauge the amount of H. pylori to which humans are exposed, 
and thus determine more appropriate doses to test in mice. Better characterizing the infectious 
dose in humans using carefully planned clinical studies would be the best way (although 
challenging ethically) to determine the infectivity of H. pylori in water. A similar protocol to the 
one used by Graham et al could be adapted for waterborne exposure 25. The data from these 
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combined efforts could be used to continue to update existing QMRAs on waterborne pathogens 
and provide evidence for the implementation of a drinking water quality standard for H. pylori.  
 
Conclusions 
In conclusion, our findings could aid quantitative microbial risk assessments for H. pylori in 
drinking water. While much research remains to be done, we have demonstrated that mice can be 
infected by drinking water contaminated with H. pylori.  
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Average CFU/L of 






Number of infected 
cages n/N (x%) by 
quantitative culture 




0 0 0/10 (0%) 0/20 (0%) 
Positive 
Control 
1.29*109 6.50*108 - 
2.16*109 
1/1 (100%) 2/2 (100%) 
2 males 
105 CFU/L 1.29*105 6.50*104 - 
2.16*105 
0/20 (0%) 0/40 (0%) 
106 CFU/L 1.29*106 5.67*104 - 
2.43*106 
1/20 (5%) 1/40 (2.5%) 
1 female 
107 CFU/L 1.29*107 6.50*106 - 
2.16*107 
3/19 (15.7%) 4/38 (10.7%) 
3 males, 1 
female 
108 CFU/L 1.29*108 5.67*106 - 
2.43*108 
19/20 (95%) 33/40 (82.5%) 
18 males, 15 
females 
109 CFU/L 1.29*109 6.50*108 -  
2.16*109 
20/20 (100%) 39/40 (97.5%) 
19 males, 20 
females 
Table 3.1. Overview of experimental results by infection status. All infected mice were confirmed by the rapid urease test, 
morphology, and PCR. 
Table 3.2: Amounts of H. pylori recovered from quantitative culture of stomach tissue and 
inflammation scoring of stomach 
Exposure group 
 







Positive Control (n=2 
mice) 
1.41*107 (9.82*106 - 
1.83*107) 
N/A N/A 
106 CFU/L (n=1 
mouse) 
1.64*107 70.97% N/A 
107 CFU/L (n=4 mice) 1.14*107 (8.47*106 - 
1.36*107) 
 
39.3% (9.1%-75%) 28.69% 
108 CFU/L (n=33 
mice) 




61.01% (0%-224%) 61.19% 
109 CFU/L (n=39 
mice) 





Table 3.2. Quantitative culture and histological inflammation results from infected mice. 
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Table 3.3: Associations between gastric inflammation and predictors 
Predictor All mice 
β(SE) 





































0.5864 -1.41% (0.47%) 0.0055 N/A N/A 
Table 3.3. Results from linear mixed models examining the associations between infection status, date of experiment, sex, 
waterborne concentration of H. pylori, and quantitative culture results on gastric inflammation taking into account cage effects. 
Associations were performed on all mice, then separately on infected and uninfected mice. 
 
 
Figure 3.1. Consistent with other results in the literature, culturability of Helicobacter pylori in water decreased steadily over 
time when kept at room temperature, with complete loss of culturability after 2 days. 
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Figure 3.2. Helicobacter pylori morphology in water: results from Bac- Light Live/Dead staining and microscopy. SB, Spiral 
bacillus morphology; Cocci, O-shaped/coccoid morphology; U, U-shape morphology. At time 0, about 90% of the H. pylori was 
spiral bacillus morphology. Over time, the percentage of spiral bacilli decreased and the percent of cocci and U-shaped 
morphologies increased. 
 
Figure 3.3. Percentage of infected mice and cages per exposure group. The infectious dose for this exposure paradigm appears 








Chapter 3.2:  Dosing Studies with the Viable-but-not-Culturable Form of H. pylori in 
Drinking Water2 
Introduction: Helicobacter pylori (H. pylori) is a gastrointestinal bacterium that causes gastritis, 
peptic ulcers and, over time, gastric adenocarcinoma1,2. H. pylori infection is hypothesized to be 
transmitted through multiple routes, including vertically from mother to child and through 
contaminated reservoirs like food and water3,4. A body of evidence suggests that contaminated 
water may be a source of H. pylori infection, with epidemiological studies consistently 
associating H. pylori infection with lack of access to potable drinking water and proper 
sanitation3,5–9. Furthermore, H. pylori has been detected in water using various molecular biology 
techniques, such as quantitative polymerase chain reaction (qPCR) and microscopy methods5,10–
                                                
2 This chapter was previously published in the journal Helicobacter: Boehnke, Kevin F., et al. "Reduced infectivity 
of waterborne viable but nonculturable Helicobacter pylori strain SS1 in mice." Helicobacter (2017). 
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13, and there are reports that it has been cultured from water14–17. H. pylori enters a viable-but-
not-culturable (VBNC) state within a few days after inoculation into water18–20. This change is 
often accompanied by a morphological change from a spiral bacillus to a U-shaped or coccoid 
form, and H. pylori has been found in the VBNC state in all these morphologies in the natural 
environment18,21. However, though H. pylori has been cultured from wastewater and drinking 
water, it is unclear whether this was due to the culturable form being present in the water or 
investigators being able to revert the VBNC form back to a culturable form using appropriate 
media.     
The fact that H. pylori is present in both a culturable and VBNC state has not been 
accounted for when assessing risk associated with waterborne H. pylori. For example, a risk 
model of waterborne H. pylori infection using a quantitative microbial risk assessment 
methodology22 did not consider the VBNC form of H. pylori. Likewise, our recent study 
showing that constant exposure to the viable, cultural form of H. pylori in drinking water can 
infect mice did not account for exposure to the VBNC form20. While previous studies found that 
VBNC H. pylori administered via gavage could cause infection in mice19,23, the gavage exposure 
method is not representative of exposure to drinking water.  To fill this gap in the literature, we 
examined the infectivity of the VBNC form of H. pylori in water.  
 
Materials and Methods:  
Transmission and Exposure groups 
Our studies were carried out sequentially following our initial dosing experiments that examined 
the infectious dose of viable, culturable H. pylori in water20. We performed four mouse 
experiments to assess the infectivity of VBNC H. pylori in various different exposure scenarios 
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(Table 1). Concentrations of VBNC H. pylori were chosen based on previous studies19,20,23 and 
on the amounts of H. pylori found in sources of recreational and drinking water worldwide24,25. 
We first employed a classic single-hit exposure model with waterborne VBNC H. pylori, 
examining whether a single day of water with a high dose of H. pylori could cause infection, 
choosing the high end of waterborne concentrations to test a ‘worst-case’ scenario and to try to 
ensure a higher chance of experimental infection. 4 weeks was chosen as the time to wait until 
euthanasia, given that She et al had found slightly increased colonization rates at 4 weeks 
compared to 3 weeks19. The sample size of 40 mice was chosen for consistency with our 
previous dosing experiments, in which each exposure group had 40 mice. When this failed to 
induce infection, we did two follow up experiments (Table 1, experiments 2 and 3). We 
increased the number of days of exposure (six instead of one), and also exposed severe combined 
immunodeficient mice to a single day of waterborne H. pylori, hypothesizing that more doses 
and immunocompromised hosts would be more likely to increase infection based on the results 
of our previous experiments20. When these also failed to induce infection, we increased the 
exposure length again and increased the number of mice to 100 to increase the likelihood of 
seeing infection. In these experiments, we used a similar experimental design to our original 
dosing studies20, exposing the mice to 56 days of contaminated water (experiment 4), and further 
decreasing the time until euthanasia. When this also failed to induce infection, we did a final 
follow-up study in which we gavaged mice with 4 doses of ~2*108 cells of VBNC SS1 over 2 
weeks. This, too, failed to induce infection.  
The mice were exposed to water contaminated with ~109 cells/L VBNC H. pylori (See 
table 1). In experiments 1-3, contaminated water was removed after 24 hours and replaced with 
either a bottle of freshly contaminated water or (when appropriate) sterilized, filtered tap water. 
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Each exposure group had 20 cages, with two mice per cage per the Animal Care and Use 
Committee regulations. In experiment 4, water was changed twice per week, every 3-4 days. As 
a negative control, 10 mice (5 cages) were given sterile, filtered tap water for 9 weeks. As a 
positive control, 10 mice (5 cages) were given sterile, filtered tap water inoculated with viable, 
culturable H. pylori for 9 weeks. All mice were housed at University Laboratory Animal 
Medicine facilities at the University of Michigan Medical School, and all experiments were 
approved by the Animal Care and Use Committee.   
 
Bacterial strain 
SS1 (Sydney Strain 1) was selected for this study for consistency with our previous studies20, and 
because it colonizes mice more successfully than other H. pylori strains26.  
 
H. pylori cultivation, counting, and inoculation 
H. pylori cultivation was carried out as previously described20. Briefly, SS1 was plated from 
stocks and grown at 37°C on 5% Sheep Blood Tryptic Soy Agar II plates (BBL, Franklin Lakes, 
New Jersey, USA) in microaerobic conditions. After 3 days, colonies were collected and 
suspended in plates of Brucella broth (Remel, Columbus, Ohio, USA) supplemented with 10% 
heat-inactivated fetal bovine serum (Fisher Scientific, Waltham, Massachussetts, USA). After 
shaking overnight in microaerobic conditions at 37°C, the broth was centrifuged at 1917g and 
4°C for 20 minutes. The supernatant was removed, and the pellet was suspended in 1x PBS. To 
confirm the concentration of H. pylori, the stock suspension was serially diluted onto 5% Sheep 
Blood Tryptic Soy Agar II plates (BBL). Sterilized, filtered tap water was then inoculated with 
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the stock suspension. After 4-7 days of growth, the number of H. pylori colonies was counted 
and the stock solution concentration was back-calculated.  
 
H. pylori viability in water  
Previous methodologies for inducing the VBNC state have differed across studies. She et 
al inoculated sterilized tap water with live H. pylori and stored it at 4°C for 40 days, defining 
cells as VBNC when they were in the coccoid state and did not grow when plated19. Wang et al 
incubated fresh H. pylori colonies in Ham’s F12 medium with 10% calf serum for 3 days, then 
stored them at 4°C, defining cells as VBNC once they stopped growing23. Cellini et al inoculated 
a Brucella broth/2% fetal calf serum solution with fresh H. pylori and incubated it for 20 days 
until the cells no longer grew when plated27. As we wanted to examine the infectivity of VBNC 
H. pylori in water, we chose to incubate H. pylori in water for the VBNC conversion. 
Inoculated water was held for 2-4 days at room temperature to ensure that the VBNC 
conversion had occurred before giving water to the mice. To check culturability, inoculated 
water was plated on 5% Sheep Blood Tryptic Soy Agar II media and incubated for 7 days in 
microaerobic conditions at 37°C. H. pylori cells were checked for viability and morphology 
using microscopy at 60x magnification and LIVE/DEAD BacLight Bacterial Viability Kit (Life 
Technologies, Eugene, Oregon, USA). To undertake viability and morphological analyses, 50mL 
of water was centrifuged at 10,400g for 3 minutes, the supernatant was removed, and cell pellets 
were suspended in BacLight Live/Dead dye. After incubating for a minimum of 15 minutes in 
the dark, the cell suspensions were examined in triplicate per the manufacturer’s instructions.  
Metabolic activity of VBNC H. pylori cells was examined using Biolog Phenotypic 
Microarray plates PM1, which contain 95 separate carbon sources which are commonly utilized 
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by a variety of microbial species. All necessary reagents were purchased from Biolog (Hayward, 
CA). H. pylori cells were grown on 5% Sheep blood Tryptic Soy Agar II media, then collected 
from the plates and suspended in sterile, autoclaved water. Cell suspensions were stored at room 
temperature for 0, 3, 4, 7, or 8 days. At each respective time point, cell suspensions were spun 
down at 1917g for 20 minutes. The supernatant was discarded, and the resulting pellets were 
checked for metabolic activity using the PM1 plate. Briefly, pellets were re-suspended in 
inoculating fluid IF-0a GN/GP (1.2x), and then supplemented to a final concentration of 0.05% 
Bovine Serum Albumin (BSA) and 1.25 mmol/L NaHCO3. (H. pylori has been shown to use 
more carbon sources and grow successfully in media containing BSA28,29, so it was included to 
ensure better visualization of metabolic activity in the VBNC state.) Dye mix D (Biolog, 
Hayward CA) was then added to achieve a final concentration of 0.01%. 100uL of this solution 
was pipetted into each well of the PM1 plate, which was then incubated in microaerobic 
conditions for 48 hours. Cells were considered to be metabolically active if they induced a color 
change in any of the wells containing nutrient sources, and the negative control had no color 
change. This was not measured in a quantitative way, but checked visually, as the purpose of this 




To estimate the doses consumed by the mice, water bottles were weighed before being placed in 
cages and immediately after their removal. Since water drips out of water bottles when they are 
placed in the cage and when the cages are moved, ‘dummy’ bottles were filled with water and 
treated in the exact same way as experimental bottles. The amount of water lost from dummy 
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bottles was averaged, and that average was subtracted from the total water lost from each bottle. 
As mice were housed two per cage, the adjusted total per cage was then halved to provide the 
individual dose per mouse.  
 
Mouse euthanasia, verification and quantification of infection 
After exposure, the mice were euthanized and their stomachs were collected. The stomach was 
weighed, homogenized in 1x PBS, and serial dilutions of the homogenate were plated on H. 
pylori selective media (Columbia blood agar base with 10% horse blood, Dent Supplement, 
300mg/L urea, and 3500U polymyxin B/L)30. Presumptive H. pylori isolates were counted and 
then checked for urease activity using urease indicator broth (0.33M urea, 0.2% Phenol Red, 
0.02% NaN3, 0.01M pH 6.5 NaPO4 buffer). DNA was extracted from stomach homogenate using 
the QiaAMP DNeasy Blood and Tissue kit (Qiagen, Hilden, Germany) per the manufacturer’s 
instructions. Extracted DNA was tested for the presence of the H. pylori VacA gene by PCR 
using the Takara PCR kit (Fisher, TAK RR001A) and primers VagA-F (5-
CAATCTGTCCAATCAAGCGAG) and VagA-R (5-GCGTCAAAATAATTCCAAGG)31. PCR 
was run with an initial denaturation at 95°C for 3 min, followed by 35 cycles of 95°C for 1 min, 
52°C for 1 min, 72°C for 1 minute, and a final extension at 72°C for 5 minutes. PCR products 
were visualized on a 1.5% agarose gel. 
 
Results 
Morphology, culturability, and metabolic activity of H. pylori in water 
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In all experiments, there was a complete loss of culturability of H. pylori 2-3 days after initial 
inoculation into water. Despite being non-culturable, cells were still found to be membrane intact 
via Live/Dead staining 8 days after inoculation into water (Figure 3.5). 
 
The VBNC H. pylori cells also induced color changes in the Biolog PM1 panels at each time 
point, respectively (Figure 3.6). This suggests that the cells were metabolically active, as they 
were metabolizing the carbon sources in each well. The cells in the viable, culturable state 
utilized many more carbon sources than any of the cells in the VBNC state. No differences in 
metabolic activity were seen between VBNC cells on days 3, 4, 7, and 8 (data not shown).  
 
Exposure to waterborne H. pylori 
A cage was counted as infected if the following conditions were met: the quantitative culture 
plates had colonies with correct H. pylori morphology (small, round, and translucent), were 
positive for the rapid urease test, and were positive for PCR targeting the VacA gene. Cages 
were counted as positive if one or both mice in a cage were infected. If no mice were infected, 
then that cage was counted as negative. The results of the five exposure scenarios and the 
positive and negative controls are summarized in Table 3.5. Further, the mice dosed with SS1 via 
gavage were also not infected.  
 
The negative controls showed no signs of infection, and confirmed H. pylori cultures were 
recovered from 8/10 positive controls. None of the mice exposed to VBNC H. pylori showed any 




We were unable to cause infection in mice with the VBNC form of SS1, either in drinking water 
or via gavage. Our inability to cause infection was surprising, given the known capacity of this 
strain to successfully infect mice26,32, our wide range of exposure scenarios, and our previously 
published study that showed that SS1 in water could infect mice in a dose-dependent manner20. 
In our previous study, 4 weeks of exposure to water spiked with 109 CFU/L, 108 CFU/L 107 
CFU/L, and 106 CFU/L of H. pylori caused infection in 39/40, 33/40, 4/38, and 1/40 mice, 
respectively. The ingested cumulative doses are 2-2000 fold lower than those used in this current 
experiment, showing that SS1 is less infectious (or completely non-infectious) in the VBNC state 
than when viable and culturable. This suggests that H. pylori strains may be less infectious than 
when viable and culturable.  
However, there are few dosing experiments in the literature that examine this 
phenomenon. She et al found that 11/16 mice gavaged with VBNC H. pylori were infected 
compared to 14/16 gavaged with the same dose of viable, culturable H. pylori19. Also using 
gavage to administer doses, Cellini et al showed that 8/20 mice were infected from VBNC H. 
pylori compared to 9/20 with viable, culturable H. pylori 27. Both studies used strains that were 
recently isolated from clinical biopsies of patients with ulcers. Combined with our results from 
drinking water and gavage exposure to SS1, this suggests that different strains may differ in their 
ability to infect mice when in the VBNC state.  
Our inability to cause infection could be due in part to the drinking water exposure route, 
which may affect the dose that reaches the stomach compared to gavage methods. Gavage 
directly inoculates the stomach with a large bolus of bacteria, while drinking water contains 
comparatively lower doses and must go through the mouth and esophagus before reaching the 
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stomach, which may result in bacterial losses along the way. While this may affect our results, 
our total cumulative doses – especially in experiment 4 – were comparable to (or higher than) the 
doses reported in previous studies (108-4*108 CFU/dose). Further, our gavage experiments 
showed no signs of infection either. Finally, our previous study in which we administered viable, 
culturable H. pylori to mice in drinking water found relatively similar dose/response rates as 
other studies that were done with gavage20. 
 
Limitations and public health implications 
As with any animal study, we cannot be certain that our results accurately reflect what would 
occur with human exposure. Since H. pylori is a human pathogen, it is possible that the VBNC 
form is more infectious in humans than in mice. Further, we only exposed mice to one strain of 
H. pylori, and it is possible that other strains would be more infectious in the VBNC state than 
SS1, as has been seen in other published papers in the literature19,27. Despite our large sample 
sizes and high doses, our inability to infect mice with VBNC H. pylori via drinking water 
suggests that VBNC SS1 in water is not infectious in mice. This may reflect the strain that we 
used, the route of exposure, or may simply mean that we did not account for some crucial piece 
of the puzzle that is yet unknown about the transmission of H. pylori via water. The genetic 
variability of H. pylori strains is vast33, so it may be possible that some strains lack the capability 
to persist in water, but instead are transmitted only via other exposures, such as person-to-person 
or fecal-oral routes4. However, if our results are true, this could imply that, since much H. 
pylori in water is in the VBNC state, that the route of drinking water does not contribute 




Examining different strains of VBNC H. pylori in these exposure scenarios would give insight 
into the trade-offs of survival and infectivity associated with the VBNC state. Further, 
investigating the distributions of VBNC vs. viable, culturable H. pylori populations in the natural 
environment would provide a better understanding of the infectivity of the various forms of H. 
pylori. Such experiments would allow for more accurate risk assessments of H. pylori in water, 
as it is very likely that multiple strains and forms of H. pylori are present in contaminated 
drinking or surface water sources.  
 
Conclusions 
We found that mice exposed to VBNC SS1 H. pylori via drinking water were not infected, 
despite the various exposure scenarios (immunocompromised, high doses) that might have 
promoted infection with VBNC bacteria. While other studies that have used viable, culturable 
SS1 to successfully infect mice via gavage and drinking water, our results suggest that VBNC 
SS1 is either not infectious (or potentially has greatly reduced infectivity). Future studies could 
examine different H. pylori strains in similar exposure scenarios to compare the relative 
infectivity of the VBNC versus the viable, culturable state, which would help inform future risk 
assessments of H. pylori in water.  
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Table 3.4. Experimental overview of exposure scenarios. 
Experiment 
number 




1 40 C57/BL6 mice (20 male, 
20 female) 
2 days Exposure to 1 day of 109 
cells/L of VBNC H. pylori.  
 
4 weeks after 
final exposure 
2 40 C57/BL6 mice (20 male, 
20 female) 
2 days Exposure to 6 days of 109 
cells/L of VBNC H. pylori^  
2 weeks after 
final exposure 
3 10 C57/BL6 Severe 
Combined Immunodeficient 
mice (4 male, 6 female) 
2 days Exposure to 1 day of 109 
cells/L of VBNC H. pylori  
1 week after 
final exposure 
4 100 C57/BL6 mice (50 male, 
50 female) 
 
4 days Consistent exposure to >109 
cells/L of VBNC H. pylori 
over 56 days  




10 C57/BL6 mice (4 male, 6 
female) 





10 C57/BL6 mice (4 male, 6 
female) 
N/A Consistent exposure to >109 
cells/L of viable, culturable 
H. pylori over 56 days  
4 days after 
final exposure 
Table 3.4. Table 1. Experimental overview of various drinking water exposure scenarios.^Mice were exposed to contaminated 
drinking water for 3 days, followed by 11 days of sterile water, and then another 3 days of contaminated water. 
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VBNC H. pylori cells 





































Experiment 3 2.22E9 5.44E6 (4.20E6 
– 6.19E6) 
0/5 (0%) 0/10 
(0%) 
0/10 


























Table 3.5. Results from viable but nonculturable H. pylori dosing experiments. While the positive control showed consistent 
levels of infection with previous studies, mice exposed to VBNC H. pylori showed no signs of infection. 
 
Figure 3.5. PM1 plates of Day 0 (viable and culturable) and Day 8 Helicobacter pylori cells (VBNC). Each well contains a 
different carbon source, and wells with a purple color change indicate that the carbon source was being used. Viable culturable 




Figure 3.6. 60x magnification of Helicobacter pylori suspension in water after 8 d of incubation at room temperature. Green 




Chapter 4  : Methods for Controlling the Spread of H. pylori Infection: 
Environmental Eradication and Clinical Treatment  
Chapter 4.1: Antibiotic Resistance among Helicobacter pylori Clinical Isolates in Lima, 
Peru.  
Introduction: Helicobacter pylori is a stomach bacterium that colonizes ~50% of people 
globally.1 H. pylori is the primary risk factor for gastric cancer - the third highest cause of global 
cancer morbidity.2 H. pylori infection rates are highly dependent on socioeconomic status; ~80% 
of those living in low socioeconomic areas of Latin America, Asia, and Eastern Europe are 
infected, compared to <20% of asymptomatic Caucasians in the US.3 H. pylori infection is 
treatable with different regimens of antibiotics,4 and eradication of H. pylori is a recognized way 
to lower incidence of gastric cancer.5 However, recurrence of infection is variable,6,7 and the 
emergence of antibiotic resistance compromises treatment efficacy. Thus, determining the best 
course of treatment is important to improve treatment efficacy and reduce recurrence of H. pylori 
infection.  
Unfortunately, there is no broad consensus about an optimal antibiotic therapy for 
treatment of H. pylori. For example, meta-analyses of European and Asian clinical data 
compared the standard triple therapy (amoxicillin, clarithromycin, and a proton pump inhibitor 
for 7-14 days) with 5 or 10 day quadruple therapy regimens (adding metronidazole or tinidazole 
to the triple therapy), and found that quadruple therapies are both significantly more effective 
and cheaper than the triple therapy.8–10 However, we previously published a study comparing 
eradication therapies in 7 sites of 6 Latin American countries that showed the 14-day triple 
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therapy was superior to the 5-day concomitant quadruple therapy, and no different than the 10-
day sequential quadruple therapy.11 These inconsistencies reflect localized differences in 
antibiotic use practices, such as the use of clarithromycin for upper respiratory infections, which 
can drive antibiotic resistance patterns in other organisms like H. pylori.12 
The differences in efficacy of antibiotic therapy are supported by primary antibiotic 
resistance data. For example, H. pylori resistance to amoxicillin varied widely between Africa 
(65.6%), Europe (0.5%), Asia (11.6%), and the Americas (2.2%).12 Even in the same region, 
patterns of resistance differ: within Central and Latin America, reported average metronidazole 
resistance varies from 30% in Argentina to 83% in Columbia, and tetracycline resistance varies 
from 2% in Brazil to 33% in Columbia.13 As such, characterizing local resistance patterns is 
important for selecting therapies with the highest likelihood of success.  
Our research focused on Peru, where gastric cancer is the leading cancer killer in men 
and women combined.14 Thus, we searched the literature for reports of primary antibiotic 
resistance to H. pylori in Peru. Three studies were identified, which reported 36.9% resistance to 
levofloxacin,15 an average of 66% resistance to metronidazole,16,17 and 50% resistance to 
clarithromycin,16 and 0% resistance to tetracycline.16 There were no data on amoxicillin, and the 
reported results of other antibiotics were based on small sample sizes, so whether their results are 
generalizable is unknown.  
As successful eradication of H. pylori infection is an important step towards prevention 
of gastric carcinoma,5,18 our objective was to assess primary H. pylori antibiotic resistance 
among 76 clinical isolates from Lima, Peru. We hypothesized that we would find similar rates of 
antibiotic resistance seen in other studies in Peru. We collected clinical isolates from  a cohort of 
patients recruited in Lima, Peru, measuring resistance to metronidazole, amoxicillin, tetracycline, 
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clarithromycin, levofloxacin, and rifampicin to cover the gamut of antibiotics used from initial 
through 2nd and 3rd line therapies.11,19 Our data found significant primary antibiotic resistance to 
first- and second-line antibiotics among H. pylori isolates from a clinical setting in Lima, Peru.20 
Methods 
Patient recruitment, treatment, and sample collection 
The study protocol was approved by the Ethics Committee of the Universidad Peruana Cayetano 
Heredia in Lima, Peru, and the Institutional Review Board of the University of Michigan in Ann 
Arbor, Michigan.  The cohort of patients from whom H. pylori isolates were obtained has been 
previously described.20 All experiments were conducted under the registered Clinical Trial Gob 
NCT015128, and SWOG clinical trial S1119. Briefly, patient recruitment occurred between 
September 2011 and August 2013 at the clinical facilities of the Universidad Peruana Cayetano 
Heredia Hospital in Metropolitan Lima. Signed, informed patient consent for procedures, 
antibiotic treatment, follow-up, and downstream molecular analyses was obtained prior to 
enrollment in the trial.  Study participants were ages 20-70 and had symptoms of dyspepsia for at 
least six months. Patients with gastric cancer or peptic ulcer disease were excluded from this 
study. Stomach biopsies were obtained via endoscopy under sedation from 109 adults 
symptomatic patients.   The diagnosis of H. pylori infection was done histologically. Six biopsies 
per patient were obtained: four for histologic studies and two for culture, which were stored in 
1.5mL of 1x PBS with 20% glycerol at -80ºC until processing. Following endoscopy, infected 
patients were treated with twice a day esomeprazole, amoxicillin, and clarithromycin for 14 days.  
Indigent patients received treatment free of charge. Patients were followed up one year after 
treatment to check for H. pylori infection status via the Urea Breath Test.20  
H. pylori isolation  
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Gastric biopsy samples thawed on ice and then homogenized using OMNI probes at maximum 
speed. (International, Kennesaw, Georgia, USA). 50µl of the homogenized sample was plated 
onto both 5% Sheep’s Blood Tryptic Soy Agar plates (Remel, Columbus, Ohio, USA) and on H. 
pylori selective media (Columbia blood agar base with 10% horse blood, 10mg/L vancomycin, 
5mg/L trimethoprim, 5mg/L cefsulodin, 5mg/L amphotericin B, 300mg/L urea, and 3500U 
polymyxin B/L).21 Plates were incubated at 37°C in microaerobic conditions for 3-7 days. 
Presumptive H. pylori isolates were subcultured, then confirmed by morphology and checked for 
urease activity using a urease indicator broth (0.33M urea, 0.2% Phenol Red, 0.02% NaN3, 
0.01M pH 6.5 NaPO4 buffer). Glycerol stocks of each isolate were prepared in Brucella Broth 
(Remel, Columbus, Ohio, USA) with 15% glycerol.  
 
Detecting vacA and cagA with PCR 
Extracted DNA from biopsy samples was tested for the presence of H. pylori cagA and vacA 
genes by PCR using previously described primers and the Takara PCR kit (Clontech, Mountain 
View, CA, USA). For cagA, previously described conditions and primers F1 (5′ 
GATAACAGGCAAGCTTTTGAGG 3′) and B1 (5′ CTGCAAAAGATTGTTTGGCAGA 3′) 
were used to amplify a 349 base pair product.22 Previously described primers VAG-F (5′-
CAATCTGTCCAATCAAGCGAG) and VAG-R (5′-GCGTCAAAATAATTCCAAGG) were 
used under the following conditions to amplify the m1/m2 subunits of the vacA gene: initial 
denaturation at 95°C for 2 min followed by 35 cycles of 95°C for 1 min, 52°C for 1 min, 72°C 
for 1 minute, completed with a final extension at 72°C for 5 minutes to amplify a 570 or 645 
base pair product.23 PCR products were visualized on a 1.5% agarose gel.   
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Antibiotic resistance and breakpoints 
Using a protocol adapted from the University of Michigan Health System Clinical Microbiology 
laboratory and bioMérieux’s instructions, H. pylori isolates were tested for susceptibility to 
amoxicillin, clarithromycin, levofloxacin, metronidazole, rifampicin, and tetracycline using E-
test® (bioMérieux, Durham, North Carolina, USA). Isolates were subcultured, then grown on 
Mueller Hinton agar supplemented with 5% sheep’s blood (Remel, Columbus, Ohio, USA). 
Colonies were collected and suspended in 1x phosphate buffered saline and visually compared to 
a 3.0 McFarland Turbidity Standard. Cell suspensions were then spread on Mueller Hinton agar 
(5% sheep’s blood) and stored for 15 minutes in microaerobic conditions, allowing the 
suspension to dry on the plate. Then, E-test® strips were placed on the plates with sterile forceps, 
and the plates were incubated for 72 hours at 37ºC in microaerobic conditions. Results were 
interpreted per the European Committee on Antimicrobial Susceptibility Testing. 24 The 
minimum inhibitory concentrations (MIC) of amoxicillin, clarithromycin, levofloxacin, 




ATCC strain 43504 (H. pylori) and ATCC 25922 (E. coli) were used as quality control strains. 
See table 4.1 for expected QC minimum inhibitory concentrations (MICs). ATCC 43504 was 
prepared and treated in the same way as unknown isolates, and was run simultaneously with each 
batch of isolates against clarithromycin, amoxicillin, metronidazole, and tetracycline. ATCC 
25922 was plated from a glycerol stock 48 hours onto an MH plate before testing, and sub-
cultured onto an MH plate 24 hours before testing. Colonies were suspended in 1x PBS to a 
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visual density of a 0.5 McFarland standard, and was run simultaneously with each batch of 
isolates against levofloxacin and rifampicin. QC results were typically within range, though 
interestingly, our reference strain of ATCC 43504 was completely resistant to metronidazole, 
and consistently had tetracycline MICs between 0.047 and 0.25 (slightly lower than usual).  
 
Breakpoints and interpretation of results 
H. pylori plates were read after 72 hours of incubation in microaerobic conditions. E. coli QC 
plates were checked after 24 hours of incubation. MICs of strains were interpreted according to 
EUCAST (European Committee on Antimicrobial Susceptibility Testing) standards, which are 
“based on epidemiological cut-off values, which distinguish wild-type isolates from those with 
reduced susceptibility”.24  
Statistical analysis 
Antibiotic resistance MICs were examined using descriptive statistics. Student’s t-tests were 
used to examine whether isolates with the m1 vs. m2 subunit of the vacA gene were resistant to 
different numbers of antibiotics.  
Results 
Seventy-six H. pylori strains were isolated from the gastric biopsies and were tested for primary 
antibiotic resistance (Table 4.2). About one third of isolates were resistant to either 
clarithromycin or amoxicillin, which are typically used for the standard triple therapy. 10.5% 
were resistant to both amoxicillin and clarithromycin, and 40.1% of strains were resistant to >3 
of the tested antibiotics (Table 4.3). Metronidazole was the antibiotic to which isolates were most 
commonly resistant (61.8%), while isolates showed least resistance to tetracycline (3.9%). 
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Resistance to levofloxacin and rifampicin among the clinical isolates was 53.9 and 46.1%, 
respectively.  
 
PCR (polymerase chain reaction) 
By PCR, all 76 strains were positive for the cagA pathogenicity island, 57/76 (75%) were 
positive for vacA m1 and 19/76 (25%) were positive for vacA m2. No differences were seen 




To our knowledge, this is the first study characterizing H. pylori primary antibiotic resistance to 
amoxicillin and rifampicin in Peru. When comparing our results to published studies, we found 
that the MIC cutoffs used were inconsistent between studies. Using a mini-well agar dilution 
method to determine antibiotic resistance, Vasquez et al. used a clarithromycin MIC of 0.125 and 
a metronidazole MIC of 4 mg/L,16, rather than the EUCAST cutoffs of 0.5 and 8, respectively.  
Our study showed comparable primary antibiotic resistance among H. pylori isolates to 
metronidazole, and slightly higher resistance to clarithromycin and levofloxacin.13,15 We 
conducted a brief meta-analysis compiling all primary antibiotic resistance data in Peru from 
ours and other reports from the literature (Table 4.4).  
 
This study demonstrates a high incidence of primary H. pylori antibiotic resistance in Lima, Peru 
to antibiotics used in the standard triple therapy. This suggests that there is a need to either 
develop new antibiotics for H. pylori eradication therapy, or to reduce the use of these antibiotics 
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for treating other infections to help protect their efficacy against H. pylori. Our study results also 
highlight the importance of continuing to characterize regional antibiotic resistance patterns to 
determine the best course of treatment  While inference from our results for clinical practice is 
limited due to our small sample size, we noted some important trends in our data and resulting 
meta-analysis. First, the small percentage of isolates resistant to tetracycline is worth examining 
in future studies to see if this trend holds. If it does, tetracycline could be of potential clinical use 
for H. pylori eradication in Lima. Second, virtually all clinical isolates tested were resistant to 
one or more of the antibiotics commonly used to treat this infection, including amoxicillin, 
clarithromycin, levofloxacin and metronidazole. This may contribute to the lower than 
anticipated response to H. pylori therapy observed in other parts of Latin America.11,25 This 
overall pattern of antibiotic resistance suggests that it may be worth considering treatment 
alternatives for H. pylori infection in Lima, Peru. We suggest that clinicians consider testing the 
antibiotic resistance profile of clinical isolates from patients with treatment-resistant infection as 
a way to guide their treatment decisions.  
An emerging appearance of H. pylori antibiotic resistance has also been reported from 
other parts of the world, including Asia, Europe and the Americas.12,13,15–17,19,26,27 This 
observation, coupled with reports of H. pylori reinfection after successful antibiotic treatment,6,7 
makes H. pylori treatment more challenging. Meanwhile, gastric cancer remains one of the most 
common and most lethal cancers in men and women combined in Peru.2,14 After accounting for 
emerging patterns of antibiotic resistance of H. pylori, it might be useful to reconsider present 
treatment practices while investigating new therapies and considering testing of H. pylori clinical 




We show high rates of primary antibiotic resistance to among H. pylori clinical isolates in Lima, 
Peru. More studies are needed to confirm this finding to optimize clinical treatment of H. pylori 
infection in Peru. 
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Table 4.1. Quality Control ranges for ATCC 43504 and 25922 
Antibiotic H. pylori strain 43504 QC Ranges E. coli strain 25922 QC Ranges 
Tetracycline 0.12-1 mg/L ---- 
Amoxicillin 0.015-0.12 mg/L ---- 
Metronidazole 64-256 mg/L ---- 
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Clarithromycin 0.015-0.12 mg/L ---- 
Levofloxacin ---- 0.008-0.06 mg/L 
Rifampicin ---- 4-16 mg/L 
Table 4.1. E-test strip quality control ranges for antibiotics used in this study.  
 
 
Table 4.2. Primary antibiotic resistance of clinical isolates from Lima, Peru.  



















27/76 (35.5%)* 3/76 (3.9%) 41/76  
(53.9%) 




0.0555 0.094 3 0.048 256 0.875 
MIC90 
(mg/L) 
256 256 32 0.125 256 32 
MIC Range 
(mg/L) 
0-256 0-256 0.25-32 0.032-32 0.25-256 0-256 
Table 4.2.  Results of MIC testing using E-test strips from Biomerieux. Susceptibility and resistance was determined using 
EUCAST standards. *5 isolates had a 0.5 ug/mL MIC for clarithromycin, which falls between the susceptible and resistant 
cutoffs for clarithromycin. For the purposes of this analysis, they were considered resistant. 
Table 4.3. Primary resistance to >1 antibiotic among clinical isolates. 














Table 4.3. Nearly all isolates were resistant to at least one antibiotic, and 70% were resistant to 2 or more. 8/76 isolates were 
resistant to both clarithromycin and amoxicillin, which are both used in the triple therapy.  
 
Table 4.4. Reported primary antibiotic resistance among H. pylori isolates from Peru using 
EUCAST guidelines.  











Berg et al, 
199717 
N/A 4.2%  
(1/24) 



























Table 4.4. Meta-analysis of primary antibiotic resistance among isolates from all studies in Peru. *6 isolates had a 
clarithromycin MIC of 0.5mg/L. For the purposes of this meta-analysis, we counted then as resistant. 
Chapter 4.2: Examination of Water Treatment Options for H. pylori Eradication 
Introduction: Helicobacter pylori is a bacterium that colonizes the human stomach. 
While H. pylori is asymptomatic in most people, it can cause peptic ulcers and has been 
categorized as a class 1 carcinogen, causing gastric adenocarcinoma 1,2. H. pylori is hypothesized 
to be transmitted directly through fecal-oral, gastro-oral, or oral-oral routes, or indirectly through 
reservoirs such as animals, contaminated food, or water 3,4. Lack of access to clean drinking 
water and proper sanitation has been consistently identified in epidemiological studies as a risk 
factor for H. pylori infection5–9. H. pylori has cultured from both wastewater and drinking 
water10–14, and has been reliably detected in recreational and drinking water using DNA-based 
molecular biology techniques such as PCR, and microscopy methods such as fluorescent in-situ 
hybridization 15–20. Further, H. pylori can survive in water distribution systems and incorporate 
into biofilms 21,22, suggesting a mechanism for sustained contamination of water supplies with H. 
pylori.  
To complicate matters, however, H. pylori rapidly enters a viable-but-not-culturable 
(VBNC) state when exposed to water, making it challenging to culture15,16,23. H. pylori in this 
VBNC state maintains metabolic activity24,25 and is membrane intact15. However, amongst the 
studies that have cultured H. pylori from water, it is uncertain whether they caused H. pylori to 
revert from the VBNC state to a viable, culturable state, or if they simply captured H. pylori in 
the viable culturable state in the environment. Since H. pylori remains difficult to culture and 
culture methods do not necessarily accurately quantify the number of viable cells, studies have 
begun to examine the use of alternative methods of quantifying viable H. pylori cells in the 
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VBNC state. One such method treats cells with propidium monoazide (PMA) upstream of 
quantitative polymerase chain reaction 26. PMA is a photoreactive dye that binds with high 
affinity and intercalates into double stranded DNA, preventing downstream amplification. While 
it can penetrate damaged cell membranes, intact cell membranes are impermeable to PMA, 
making it a useful agent for determining between viable and non-viable cells. This method has 
been used successfully to examine dynamics of H. pylori survival in room temperature water, in 
drinking water distribution systems, in cohabitation with amoebas, and against treatment with 
ozone26–30. 
Despite these unknowns, H. pylori in water – be it VBNC or viable and culturable – may 
pose a risk to human health. The afore-mentioned epidemiological associations provide a link 
between contaminated water and H. pylori infection, several studies have shown that VBNC H. 
pylori is infectious in mice via gavage31–33, and we previously showed that waterborne viable 
culturable H. pylori is infectious in mice34. This evidence provides motivation for examining 
potential interventions that could eradicate or remove H. pylori from drinking water, both in 
municipal treatment processes as well as with point-of-use options when municipal water is not 
available or is of poor quality.  
However, there remains a dearth of literature around water treatment options for H. 
pylori. H. pylori can survive in this VBNC state even when exposed to common disinfectants; 
after exposure to 0.8mg/L chlorine in drinking water for 24 hours, H. pylori still maintained gene 
expression of the toxin VacA during that time16. H. pylori is also more resistant to low levels of 
chlorine (0.1-0.3 mg/L) and ozone (0.05-0.125 mg/L) than E. coli, but similarly susceptible to 
monochloramine. However, the evaluation of other cost-effective water treatment methods, like 
boiling, have not been examined.   
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 Thus, the objective of our study was to use PMA-qPCR and culture techniques to 
examine the effectiveness of boiling water and bleach disinfection for H. pylori eradication in 
drinking water. Since user compliance of household drinking water treatment techniques varies 
substantially35, we tested the efficacy of the treatment methods in multiple different exposure 
scenarios. We hypothesized that longer exposure to bleach or boiling disinfection would result in 
effective eradication of H. pylori by both culture-dependent and –independent methods. We 
further hypothesized that boiling disinfection would be more effective than bleach disinfection, 
given that H. pylori appears to be able to retain some metabolic function even after longer 
exposures to chlorine in water6.  
 
Methods 
Culture of H. pylori and inoculation 
H. pylori strain SS1 was used in all experiments. Tryptic Soy Agar II plates with 5% sheep’s 
blood (Remel) was inoculated with glycerol stocks of SS1 and incubated in microaerobic 
conditions at 37°C for 3 days. The resulting colonies were collected and suspended in 1x PBS, 
and this solution was serially diluted and plated on TSA II plates (5% sheep’s blood) and 
incubated in microaerobic conditions at 37°C for 7 days to calculate the quantity of input cells. 
The remaining cell suspension was used to inoculate sterile filtered tap water to examine the 
effectiveness of the various treatment scenarios.  
 
Boiling  
H. pylori was added to an Erlenmeyer flask containing 250mL of room temperature sterile 
filtered tap water, and then heated until it had just begun to boil, boiled for 1 minute, or boiled 
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for 5 minutes. The flask was then cooled to room temperature, and then vacuum concentrated as 
described below.  
 
Chlorine exposure 
Sodium hypochlorite solution was added to room temperature sterile filtered tap water, then 
allowed to equilibrate in solution for 5 minutes. After 5 minutes, the free available chlorine 
concentration was measured with a Hach Spectrophotometer (average concentrations of 3.06-
3.46mg/L). Then, H. pylori stock solution was added to the chlorinated water and held at room 
temperature for 5, 15, and 30 minutes. After exposure to chlorine, several grains of sodium 
thiosulfate were added to remove any residual chlorine, which was confirmed by a Hach 
Spectrophotometer. The cells were then vacuum concentrated as described below. 
 
Concentration of cells  
Water was vacuum concentrated onto 0.22µM membranes. Membranes were gently scraped into 
1x PBS to remove the bacteria. This solution was transferred to 1.5mL microcentrifuge tubes and 
centrifuged for 6 minutes at 3000 rpm. The supernatant was removed and pellet was re-
suspended in 1100 µL of 1xPBS. To test for culturability of treated cells, 100 µL of this new cell 
suspension was plated onto TSA II 5% Sheep’s Blood agar (Remel) and incubated in 
microaerobic conditions at 37°C for 14 days. The remaining sample was split into 2 




The following method for PMA treatment was adapted from Augusti et al. (2010). 1.25 µL of 
Propidium monoazide (PMA) was added to one duplicate of each 500 µL sample. The other 
duplicate was used as a control: this sample represented the total number of cells recovered after 
treatment, as downstream qPCR would measure DNA from all cells in this suspension, be they 
viable, VBNC, or dead. After the PMA addition, samples inverted >25 times to mix, and then 
were kept in the dark for 5 minutes. Next, samples were placed on ice and positioned 20cm away 
from 600W high intensity light for 15 minutes, turning and inverting every few minutes to ensure 
suspension homogeneity and to avoid overheating. After exposure to light, the tubes were 
centrifuged for 5 minutes at 14,000g. DNA extraction was then carried out using the Qiagen 
QiaAmp Mini Kit according to the manufacturer’s instructions. 
 
Control cells: not boiled or exposed to bleach 
To examine if any cell damage or loss of culturability occurred in untreated cells, suspensions of 
freshly grown H. pylori were inoculated into sterilized tap water for 0, 1, 5, 15, and 30 minutes. 
After the requisite waiting period, the cells were concentrated by vacuum filtration, and then 
plated and treated with PMA in the same way as samples exposed to either chlorine or boiling.  
 
Percent recovery calculations 
In the treatment and control trials, percent recovery was calculated by dividing the total number 
of input cells (culturable) by the total number of cells measured by qPCR in aliquots that were 
not PMA treated (See PMA Treatment).  
 
qPCR (quantitative polymerase chain reaction)  
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qPCR was performed on extracted DNA using the method from Janzon et al. (2009)36. Briefly, 
quantities of H. pylori were quantified using a reaction mixture containing 10ul 2×SYBR 
GREEN PCR Master Mix (Applied Biosystems, Grand Island, NY, USA), 0.3 µL of each 20 µM 
primers HpA-F (ACTTTCTCGCTAGCTGGATGGTA) and HpA-R 
(GCGAGCGTGGTGGCTTT), 8.4µL of sterile PCR water, and 1 µL of DNA template. Plates 
also included negative controls (no DNA added) and positive controls (H. pylori DNA), and a 
standard curve made with 10E2 to 10E7 genome copies of H. pylori strain SS1 DNA. qPCR was 
run at the following conditions: 95°C for 10 minutes, 45 cycles of 95°C for 15 seconds and 60°C 
for 1 minute, followed by a melting curve analysis, ramping from 60°C to 95°. 
 
Statistical analysis 
Student’s t-tests were used to compare differences in the mean log-reduction between boiling 
and bleach trials. One-way ANOVAs were used to compare the log-reduction measured by 
PMA-qPCR between 5, 15, and 30 minutes of exposure to bleach, and between 0, 1, and 5 
minutes of exposure to boiling water.  
 
Results 
The results of the bleach and boiling trials are summarized in tables 4.5 and 4.6, respectively. 
Figure 4.1 shows the compiled PMA-qPCR results of boiling, bleach, and controls trials. 
Culturability was completely lost in all bleach and boiling trials, resulting in a ~8 log reduction 
in culturable cells. This result was seen regardless of the exposure length. Surprisingly, we saw a 
much lower log-reduction (1.32-1.49) using the PMA-qPCR method in both boiling and bleach 
trials. No significant differences were seen between the PMA-qPCR results for bleach trials (F-
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statistic=0.12, p=0.88) or for the boiling trials (F-statistic=0.28, p=0.76), regardless of the length 
of exposure to each respective disinfection technique. This was also surprising, as we expected to 
see that longer exposure to disinfection would result in increased eradication of H. pylori cells. 
No significant differences were seen between the mean PMA-qPCR results between bleach and 
boiling trials (0.03, 95% CI [-0.21, 0.27], p=0.8). There were statistically significant differences 
between the average log-reduction by PMA-qPCR of control trials vs. exposure trials (0.65, 95% 
CI: [0.44, 0.86], p<0.0005). 
 
The results of the control trials are summarized in table 4.7. As expected, culturable cells were 
recovered at each time point, with a general trend of a slightly decreased number of cells 
recovered with increasing time. Culturability decreased by 1.56-2 log, with a general increasing 
trend as the length of exposure to drinking water increased. Given the ~8 log-reduction seen in 
the disinfection trials, this suggests that both bleach and boiling disinfection result in ~6 log-
reduction of H. pylori cells by the culture-based method.  
However, no such trend among controls was seen with the PMA-qPCR method: cells 
exposed to water for 5 minutes showed the greatest log-reduction by qPCR (0.92), while cells 
exposed for 30 minutes only showed a log-reduction of 0.71. In both the boiling trials and the 
control trials, there was one instance in which the total recovered cells exceed 100%. This may 
be because there were some dead or VBNC cells in the initial inoculum, which resulted in a 
higher quantity of genomic DNA than the total number of culturable cells.  
Discussion: 
In our present study, we found that boiling and bleach disinfection treatments, regardless 
of exposure length, reduced culturability in H. pylori cells, by ~6 log. However, H. pylori’s 
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conversion to a VBNC state reflects a limitation of culture-based methodology. When using the 
culture-independent technique of PMA qPCR, we did not see a consistent or significant dose-
response in our exposure methods between H. pylori exposed to a minimal level of disinfection 
(e.g. 0 minutes of boiling or 5 minutes of chlorine disinfection) vs. a longer time exposure (i.e. 5 
minutes of boiling or 30 minutes of bleach exposure). Nor did we see consistency between 
culture-based and the culture-independent methods, as there was a >6-log difference between 
them. Based on the culture methods, these study results were somewhat consistent with our 
hypothesis that boiling and bleach disinfection could successfully remove H. pylori. However, 
we saw no support for our hypothesis that boiling disinfection would be more effective than 
bleach disinfection, and the PMA-qPCR results cast doubt on the efficacy of either of these 
methods for successful eradication of H. pylori from drinking water due to the conversion of H. 
pylori .  
This leads to two potential inferences. First, that PMA-qPCR may not be appropriate for 
use as a culture-independent technique for testing the H. pylori reduction capacities of water 
treatment devices. A remarkably similar pattern was observed when using PMA-qPCR vs. 
culture methods to investigate monochloramine disinfection of bacteria in the effluent of 
biologically active carbon37: there was an ~1.5 log reduction by PMA-qPCR, and ~4-log 
reduction in culturability using the heterotrophic plate count method. While another recent study 
showed a 4-5 log decrease in coccoid H. pylori using PMA qPCR following ozone disinfection30, 
the authors calculated their log-reduction by comparing their disinfected, PMA-treated cells to 
cells that were neither disinfected nor PMA-treated, which over-estimates the effectiveness of 
their technique. The cells in that experiment were held at 10 days at room temperature, which, 
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based on viability estimates from other experiments26, would have already undergone at least ~2 
log reduction by that time, potentially compromising the validity of those results.  
Second, this could suggest that H. pylori is in some way uniquely resistant to boiling and 
bleach disinfection. While little data exists on the efficacy of boiling to remove H. pylori, 
Moreno et al. (2007) found that H. pylori can survive in the VBNC state for 3 hours in 
chlorinated water (0.96mg/L – 1.16mg/L Cl2), and can continue producing the toxin VacA in the 
presence of chlorine for over 24 hours16. Further, Baker et al found that H. pylori is more 
resistant to chlorine disinfection than E. coli, having a slower decrease in loss of culturability at 
low doses of chlorine (0.1-0.3mg/L)38. While this is intriguing, more research is needed to tease 
out whether this holds in other scenarios as well.  
However, our study does have important limitations. First, and most importantly, we 
cannot determine whether the H. pylori cells in our PMA-qPCR assays were in VBNC state, or 
dead/dying but still membrane-intact (rendering them viable by PMA-qPCR). Until more reliable 
methods are developed to quantitatively differentiate between cells in these different states, 
accurately measuring the ability of water treatment systems to remove H. pylori will remain 
difficult, as we found in our current study. Second, we are uncertain that loss of culturability 
actually results in cell death, since, as mentioned above, H. pylori can still produce its primary 
toxin after 24 hours of exposure to chlorine16. Finally, we used sterilized, filtered tap water in our 
study, which is not representative of drinking water in nearly any setting. Thus, it is possible that 
other water characteristics or co-contamination with other bacteria or toxicants may affect the 
disinfection capabilities of our treatment methods.  
In conclusion, we found that both boiling and chlorine disinfection were capable of 
quickly reducing culturability in H. pylori strain SS1. However, PMA-qPCR, while it may be 
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useful in some contexts, does not appear to be a good way of measuring the efficiency of boiling 
and bleach disinfection for eradicating H. pylori. More research is needed to further examine this 
relationship and optimize culture-independent methods to gauge the relative population 
proportions of H. pylori in drinking water.  
 
Conclusions: H. pylori transmission in water seems plausible given the strong epidemiological 
associations and consistent findings of water contaminated with H. pylori. Based on the culture-
dependent eradication rates, both boiling and bleach disinfection appear to be relatively suitable 
for treating H. pylori-contaminated water. More research is needed to develop better culture-
independent techniques that quantify the presence of VBNC H. pylori in water.  
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2.46 (0.58) 2.40E9 
(7.53E8) 







1.89 (0.53) 2.40E9 
(7.53E8) 







1.10 (0.57) 1.54E9 
(5.02E8) 
21.6 (17.1) 1.40 
(0.29) 
NO 
Table 4.5. No differences were seen between the different time trials with regards to culturability. With regards to PMA-treated 
cells, there were no differences seen between the log-reduction in cells based on treatment length. 
Table 4.6: Overview of Boiling trials. 
 
Boiling Trials 














0 minutes (water 
was brought to a 
boil and then 
removed from heat) 
5 1.94E9 
(1.13E9) 
69.6 (63.7) 1.36 (0.55) NO 
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1 minute 6 1.43E9 
(8.11E8) 
30.9 (41.2) 1.49 (0.32) NO 
5 minutes 5 1.94E9 
(1.13E9) 
123.1 (122.4)* 1.33 (0.18) NO 
Table 4.6. Boiling trial results. No differences were seen between the different time trials with regards to culturability. With 
regards to PMA-treated cells, there were no differences seen between the log-reduction in cells based on treatment length. *: 
Percent recovery is higher than 100% due to the denominator being the total number of input culturable cells. qPCR captures all 
cells, including non-viable cells and VBNC cells, which is why this value is higher.  
Table 4.7: Overview of control trials.  
 
Control Trials 











0 minutes: added to water 
then immediately vacuum 
concentrated 
2 113 (71.8)* 0.67 (0.43) 1.56 (0.26) 
1 minute 2 48 (35.3) 0.63 (0.20) 1.78 (0.46) 
5 minutes 2 94.9 (37.6) 0.92 (0.37) 1.86 (1.07) 
15 minutes 2 59.4 (8.6) 0.72 (0.34) 1.83 (0.46) 
30 minutes 2 88.9 (41.3) 0.71 (0.59) 2.0 (0.79) 
Average 2 80.86 (38.9) 
 
0.73 (0.10) 1.81 (0.61) 
Table 4.7. Results from the control trials. *: Percent recovery is higher than 100% due to the denominator being the total number 




Figure 4.1. Comparison of log reduction due to boiling, bleach disinfection, and control treatment in exposed cells. No 
significant differences were seen between boiling and bleach disinfection. Control cells showed consistently lower log-reduction 
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Chapter 5  : Conclusions 
This dissertation investigated the role of contaminated water as a potential transmission 
route for H. pylori infection in Lima, Peru. The main contributions of this dissertation to our 
understanding of the risk of H. pylori in drinking water relate to potential differences in 
infectivity between the viable culture and VBNC state and the importance of exposure route 
(drinking water versus gavage).  
In Chapter 2, we conducted an exposure assessment of H. pylori in drinking water in 
Lima, Peru, sampling water from: the homes of patients in a clinical cohort, wells that 
supplement the municipal drinking water treatment system, finished water from the treatment 
plant, and a sink in the Lince district. We found that water in Lima was consistently 
contaminated with H. pylori. Of the water collected from patient homes, 48% (n=42/87) of 
drinking water samples were positive. All samples of source water (n=2) and finished water 
directly from the municipal plant (n=2) were positive for H. pylori. 60% (n=3/5) well-water 
samples, and 22.5% (58/258) of samples collected from the Lince district were positive for H. 
pylori. While there were some statistically significant associations between pH and the quantity 
of H. pylori as well as between temperature and the presence of H. pylori, these associations 
were not in the expected direction. Thus, they may reflect stochastic events (such as shedding 
from biofilm or infusions of contaminated water from leaks in the distribution system) that were 
not captured in the variables used as model inputs. Taken together, these results show that water 
in Lima is regularly contaminated with H. pylori, which is consistent with results seen in many 
other developing countries throughout the world1–9. This suggests that H. pylori can either 
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propagate or survive in drinking water in Peru.  However, the major limitation of this study was 
our inability to determine the relative population proportions of H. pylori in water, i.e. viable and 
culturable, VBNC, or dead/dying. Future studies and methods are needed to quantitatively 
examine the proportions of these cell populations to better understand the risk of waterborne H. 
pylori.  
In Chapter 3, we investigated the infectious potential of H. pylori in drinking water using 
a mouse model. First, we exposed mice to various doses of viable, culturable H. pylori strain SS1 
in drinking water, and found that they were infected in a dose-dependent manner10. Next, we 
exposed mice to various exposure scenarios of VBNC H. pylori strain SS1 in drinking water. 
Surprisingly, we were unable to induce infection using VBNC H. pylori, even after 56 days of 
exposure to >109 cells/L11. We further investigated the infectious potential of VBNC SS1 using 
gavage, giving 4 doses of ~2.5*108 cells/dose to mice over 2 weeks. This also failed to induce 
infection. Given these results, we concluded that while viable, culturable H. pylori appears to be 
infectious in water, the infectivity of VBNC H. pylori is less certain. Other investigators have 
been able to cause infection in mouse models via gavage using H. pylori strains recently isolated 
from human gastric biopsy samples12–14, suggesting that there may be variability in infectivity 
between strains. Since we only used one strain of bacteria, and the genetic diversity of H. pylori 
is vast 15, it is possible that there could be some strains of H. pylori that are better suited to infect 
hosts via water compared to other routes. Finally, this could imply that, since much H. pylori in 
water is in the VBNC state, that the route of drinking water does not contribute significantly to 
the transmission of H. pylori infection.  
In Chapter 4, we examined clinical and environmental methods for controlling H. pylori 
infection. Clinically, we found high rates of primary antibiotic resistance to amoxicillin and 
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clarithromycin, which are typically used as first-line treatment of H. pylori in Lima16. After 
including our results in a meta-analysis of primary antibiotic resistance in Peru17–19, we found 
that overall rates of antibiotic resistance are quite high, including in antibiotics used in the 
standard triple therapy (amoxicillin: 32.9%, clarithromycin 29.7%, metronidazole 59.1%) and in 
second- and third-line treatments (rifampicin 46.1%, levofloxacin 44.4%). However, we found 
that primary resistance to tetracycline is low, suggesting the clinical potential for tetracycline in 
the future. Due to these high rates of antibiotic resistance, we conclude that approaches that help 
prevent infection would be useful to pursue. Further, to help quell antibiotic resistance, we 
suggest that clinicians should perform antibiotic resistance profiling of clinical isolates before 
starting antibiotic treatment. However, given the low number of studies and overall isolates that 
have examined primary antibiotic resistance and treatment success in Peru, more studies are 
needed to properly inform clinical practice. These results also highlight the importance of 
characterizing regional antibiotic resistance patterns, as the compiled results for antibiotic 
resistance in Peru are quite different from those in other areas of the world20,21.  
We then investigated the disinfection potential of bleach and boiling water for eradicating 
H. pylori, using both culture-dependent (plating) and -independent (PMA-qPCR) methods to 
estimate disinfection efficiency. After exposure to either 0, 1, or 5 minutes of boiling or 5, 15, or 
30 minutes of bleach, all culturability of exposed cells was lost – a >6 log reduction. When using 
culture-independent methodology, these disinfection methods caused an average of 1.3-1.5 log-
reduction in the number of membrane intact cells, with no dose-dependent effects. Though this 
mismatch was puzzling, this has also been observed elsewhere in the literature. After exposure to 
monochloramine, the heterotrophic plate count of effluent from water filters showed a 4.5 log-
reduction, while the same cells measured by PMA-qPCR showed an ~1.5 log-reduction22. This 
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suggests that PMA-qPCR may not be an appropriate method for measuring water-treatment 
efficacy, and further reinforces the need to develop new methods to differentiate between 
VBNC, viable culturable, and dead H. pylori cells to accurately estimate the effectiveness of 
these different treatment options.  
 
Risk of infection from waterborne H. pylori? 
In reviewing the literature, we found only one published quantitative microbial risk assessment 
of H. pylori in drinking water23. The exposure assessment was based on quantities of H. pylori 
found in surface water in the United States, and assumed that “1 gene copy/L is equivalent to… 1 
CFU/L or 1 organism/L”. The dose-response examination evaluated the risk of infection based 
on studies that used the infectious dose of viable, culturable H. pylori in monkeys and humans 
administered via gavage or oral routes. The authors concluded that a maximum contaminant 
level of <1 organism/L was necessary to meet a goal of 1/10000 annual infection risk. However, 
this risk assessment could be updated based the findings from this dissertation, which suggest 
that more nuanced approaches are needed.  
In the exposure assessment in chapter 2, we conducted year-long time-series sampling 
campaign of H. pylori in drinking water, which could be used as a more accurate input for Lima 
than surface water found in the USA. However, the quantities of H. pylori in finished drinking 
water that were far higher than those used in the model inputs, and contamination ~20% of the 
time in our time-series exposure assessment. Had these data been used as inputs in the model, the 
calculated risk of infection would have likely been much higher, but would have failed to 
incorporate the important nuanced difference between viable culturable, VBNC, and dead cells – 
something that we could not capture in our DNA-based method. This highlights the need to 
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develop risk scenarios that account for variable proportions of VBNC, viable culturable, and 
dead H. pylori cells in drinking water. 
The dosing study in chapter 3 that used viable, culturable H. pylori had exposure groups 
with much larger sample sizes than those used in the published QMRA (n=38-40 per exposure 
group vs. n=2-3), and used waterborne H. pylori opposed to oral or gavage exposure. Thus, 
validating whether H. pylori infectivity in mice is representative of that in humans, and 
potentially updating the dose-response of viable, culturable H. pylori with the mouse data from 
this aim could strengthen further risk assessments. Next, the second set of dosing experiments in 
chapter 3 suggest variability in infectivity between VBNC and viable, culturable cells of strain 
SS1. Given that H. pylori typically exists in the VBNC form in water, this suggests that using a 
dose-response that relies on viable, culturable data may not be reliable. Given that gavage studies 
with different strains of VBNC H. pylori show that it can be infectious in mice12,14, this  
highlights the need for studies that better elucidate the infectious dose of various VBNC H. 
pylori strains in drinking water, as well as coordinating dose-response models with exposure 
assessments appropriately to estimate the risk of waterborne H. pylori.  
 
Future directions 
While our results show contamination of drinking water in Lima with H. pylori, our mouse 
studies cast doubt on the infectious potential of VBNC H. pylori in drinking water. However, our 
single study is not sufficient to fully validate this claim. There remain many unknowns that must 
be better understood. To perform accurate risk assessments, new methods are needed to tease out 
population dynamics of H. pylori in water, which would provide better estimates of the number 
of cells that are VBNC, dead/dying, or viable and culturable. Such studies should also seek to 
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understand the relationship between water characteristics, such as pH and temperature, and the 
relative frequency of each form of H. pylori. Further, as culture-based methods become more 
standardized and accessible, it may become easier to examine the infectivity of different strains 
of H. pylori, especially those that seem to propagate most successfully in water. Different strains 
of H. pylori may be differently infectious in the VBNC state, as is suggested by the successful 
dosing studies (albeit via gavage rather than waterborne transmission) performed with various 
strains isolated from peptic ulcer patients12–14.  Additional investigations of such strains would 
increase the precision of dose-response estimation that gauge risk of infection. Finally, H. pylori 
can cohabitate with amoebae and zooplankton, which may protect it from disinfection, help it 
survive successfully in water, and potentially allow it to be transmitted more effectively to 
humans24–26. Further investigation of interactions between H. pylori and such organisms would 
inform exposure scenarios that might affect the likelihood of infection from waterborne H. 
pylori. Once such data are available, accurately assessing the risk of waterborne H. pylori will 
become more possible.  
 
Contributions of the Integrated Assessment approach 
Our Integrated Assessment approach resulted in a dynamic idea exchange between study teams 
at the University of Michigan and in Peru. After seeing the water contamination results from our 
initial clinical study (see Appendix A), officials at the Directorate General of Environmental 
Health and Food Safety (DIGESA) were interested in collecting more data. Based on their 
suggestions, and with the assistance of a DIGESA microbiologist, we were able to pursue 
additional sampling, culminating in the study results shown in Chapter 2.1. Similarly, after we 
presented our water contamination results at a workshop in Lima, we were asked whether the 
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quantities of H. pylori we found in drinking water were a cause for concern. This question led to 
the extensive dosing experiments covered in chapter 3, which were the first to examine the 
infectivity of viable, culturable H. pylori and VBNC H. pylori in drinking water. Finally, after 
discussing the importance of developing targeted treatment of H. pylori clinical infection, we 
conducted our antibiotic resistance testing study in Chapter 4.1. The methods used from this 
study and the results gleaned will help guide future clinical studies at the Universidad Peruana 
Cayetano Heredia, where our collaborator Dr. Alejandro Bussalleu is now conducting antibiotic 
resistance testing of clinical isolates from Lima using the same methodology. I am very grateful 
that I had the opportunity to work with the many dedicated individuals from both Peru and 
Michigan on this project, as it gave me a greater awareness of the importance of incorporating 
multiple viewpoints when designing studies to improve public health.  
 
Conclusions  
Taken together, our results show that: 1) water in Lima is consistently contaminated with H. 
pylori, 2) VBNC H. pylori in drinking water may not be a large contributor to overall H. pylori 
transmission, given our failure to infect mice using VBNC H. pylori, 3) antibiotic resistance is 
high in Lima, and treatment success is lower than expected based on trials in 7 Latin American 
countries27,28, and 4) there is uncertainty about the efficacy of existing water treatment 
technologies for eradicating H. pylori in drinking water. Based on these data, we cannot make 
any recommendations for policy decisions related to drinking water and H. pylori, as more 
studies are needed to better evaluate the risk from waterborne H. pylori. However, this does not 
mean that unimportant to improve access to clean water and sanitation in Lima. Investing in 
water treatment infrastructure for drinking water and sanitation has been shown to be both 
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important for saving lives as well as being cost-effective. An estimated 842,000 deaths from 
diarrheal disease occur each year due to inadequate drinking water, sanitation29, and water-
related hygiene, and investments in water infrastructure can yield up to seven dollars for every 
dollar invested30. For additional control measure, measures should be taken to maintain treatment 
efficacy in the era of antibiotic resistance. These include phenotyping antibiotic resistance 
profiles of clinical isolates, and creating a database for clinicians to record treatment success 
rates of various treatment regimens, as well as antibiotic resistance patterns from their clinics.  
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Chapter 6  : Final Thoughts on Science and the PhD Process3 
Throughout my science education, I have dutifully memorized facts: the stages of 
photosynthesis, the enzymes involved in the Krebs cycle, how to balance equations in chemical 
reactions. In contrast, the focus of my ancient history classes was on answering big, open-ended 
questions: Why did historical figures act in certain ways? How did the assassination of Julius 
Caesar affect the Roman Empire? Would our world be different had he not been murdered? 
There were other questions, too, related not just to historical events but to the nature of 
knowledge, to what we know and how we know it. What's the evidence? How reliable is it? Does 
the conventional explanation account for all the available information (including competing 
ideas) and the broader context? 
Eventually, I tried applying a similar thought process to my scientific interests. I found that 
approach to science much more appealing—and also useful. I took it with me as I became a 
scientist. 
Brushes with waterborne illness and professional experiences with water filtration inspired me to 
pursue a Ph.D. in public health, focusing on the waterborne transmission of Helicobacter 
pylori in Lima. I chose it because it's a big-picture project, a collaboration between public health 
                                                
3 Published in the journal Science: Boehnke, Kevin. "Oh the humanities!." Science 347.6226 (2015): 1166-1166. 
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officials, scientists, and doctors with the shared goal of providing data-driven advice to 
policymakers. 
I rapidly discovered that new data, or a new technical approach, won't solve access to clean 
water. After all, the technology to improve water quality is already available, and water-
treatment infrastructure is known to be cost-effective. The problem persists because the 
challenge of clean water ties into complex political and social issues: culture, economics, 
science, emotion, ideology. You can't solve such problems without accounting for the bigger 
picture. Narrow thinking can even lead to strategies that do harm, like privatization efforts in 
Peru that modestly improved water infrastructure but priced the poor out of the market. As our 
challenges become more complex, even strictly scientific problems require a broader 
perspective, akin to that embraced by historians, philosophers, and other humanist scholars. 
I have benefited from studying history in other ways. I learned to think critically and to write 
rigorous, compelling qualitative arguments. Slashed research budgets make writing about 
broader impacts more crucial than ever. Academic scientists must defend their work against 
competing political and economic priorities, not just in grant proposals but also in public and 
political spheres. Scientists are increasingly involved with governments and policymakers: Every 
year, we've had to justify our research project to a new Peruvian minister of health in order to 
legally continue. 
As stable academic science positions stagnate, a growing proportion of scientists seek 
employment outside academia. Private-sector and governmental careers usually require thinking 
that encompasses regulatory and cultural concerns—and pragmatic concerns like profits. The 
 102 
ability to consider and weigh diverse arguments and to communicate clearly with various 
stakeholders is essential. 
Science's inherently reductive approach and its acute attention to the finest details have yielded 
great benefits. But the scope of science is changing. In addition to practicing the traditional craft, 
today's scientists need to be prepared to tackle complex challenges in a globalized (and 
multidisciplinary) world, to think critically about how we solve problems, and to communicate 
persuasively with diverse audiences. More than my science classes did, studying history taught 
me these skills. Scientists can be too eager to write off other disciplines as “soft,” subjective, and 
therefore inferior to science and its rigorous approach. Those other fields, though, can enhance 
the practice and understanding of science, among scientists and the public. I encourage my peers 
to think about science in this larger context, as a liberal art intrinsically tied to its cousins and 
aimed at illuminating, improving, and adding meaning to the human experience. 
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Appendix A: Clinical, Epidemiologic, and Genomic Studies (SWOG S1119) of 
Helicobacter pylori in Lima, Peru: Role of Contaminated Water4 
 
Introduction 
Helicobacter pylori (H. pylori) is a bacterium that infects the stomachs of one-half of 
the world’s population, including 80% of those living in low socioeconomic areas of Latin 
America, Asia, and Eastern Europe. By contrast, less than 20% of asymptomatic Caucasians 
carry H. pylori in the USA1. H. pylori is a Group 1 carcinogen because of its direct causal 
relationship to gastric carcinoma2. The WHO estimates that for 2008, there were globally over 
989,600 new diagnoses and 738,000 deaths from gastric cancer3. In Peru, gastric cancer is the 
most common cancer and cause of cancer mortality in men and women combined4. 
 
Most accept that fecal-oral, oral-oral, and gastro-oral transmission from mother to child is the 
principal mechanism of H. pylori infection. However, a genotypic study in shantytown 
households in Lima, Peru, showed 70% discordance between the H. pylori strains from mother, 
children, and others in the family. These results suggest this infection is community acquired and 
that there may be other sources of infection5. Historically, drinking water from the La Atarjea 
water treatment plant, Lima’s primary source of drinking water, has tested positive for H. pylori 
in 50% of 48 samples6,7. This information correlated with the frequency of H. pylori infection in 
children, their socioeconomic status, and the type of water they drank. The presence of H. pylori 
                                                
4 This chapter was previously published in the Journal of Cancerology: Valdivieso M, Bussalleu A, Sexton R, 
Boehnke K, Osorio S, Reyes IN, et al. Clinical, Epidemiologic, and Genomic Studies (SWOG S1119) of 
Helicobacter Pylori in Lima, Peru: Role of Contaminated Water. J Cancerol [Internet]. 2016;3(2):52–63. Available 
from: http://www.journalofcancerology.com/resumen.asp?id=55&indice=2016032 
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in drinking water by polymerase chain reaction (PCR), the high reinfection rate, and the genomic 
heterogeneity of this organism in Lima suggest that contaminated water may play a role in the 
transmission of the infection5–8. 
 
The distribution of gastric carcinoma in Metropolitan Lima, a surrogate of H. pylori infection, is 
highest in the lower socioeconomic areas of Puente Piedra, Lince, Villa El Salvador, El 
Agustino, Breña, and Rimac (21-25/100,000) and lowest in high socioeconomic areas such as 
San Isidro and Miraflores (9-13/100,000)4. The treatment of H. pylori infection is effective in 
approximately 80-90% of patients, with best results attributed to sequential regimens9. There is, 
however, an increasing rate of treatment failure due to antibiotic resistance, particularly to 
clarithromycin10–12. The rate of annual recurrence is higher in developing countries than in 
developed countries (13 vs. 2.67%, respectively) and recurrence rates are variable, 
though high, in Latin America11–14. The highest percentage of infection recurrence has been 
reported in Peru: 73% at eight months and 30% at 18 months6,8,15. In other Latin American 
countries, the annual reported infection recurrence rate is as high as 54% in Chile, 50% in Brazil, 
and 37% in Mexico14. The high recurrence rates indicate that reinfection from environmental 
sources is possible, leading us to our current study. 
 
This study was conducted based on the hypothesis that the drinking water in Lima was 





The study protocol was approved by the Ethics Committee of the Universidad Peruana Cayetano 
Heredia in Lima, Peru, and the Institutional Review Board of the University of Michigan in Ann 
Arbor, Michigan. Signed informed consent form was required. The study opened on September 
1, 2011 with patient accrual completed on August 5, 2013. The protocol was opened in high- and 
low-risk areas simultaneously. Patients were followed for a year after therapy. All authors had 
access to the study data and reviewed and approved the final manuscript. 
 
Patients 
We targeted 100 adults between the ages of 20 and 70 with symptoms of dyspepsia for at least 
six months and with indications for gastroscopy (approximately 80 patients from high-risk areas 
and 20 from low-risk areas). The presence of peptic ulcer disease and gastric cancer were 
exclusion criteria for the study. Patients would have a histologic diagnosis of H. pylori gastric 
infection and a Zubrod's performance status of 0 to 2. As a result, there would be gastric biopsy 
positive and negative patients for H. pylori infection. Patients would have resided in the same 
target districts for at least 10 years. Patients were invited to respond to three questionnaires: (i) 
risk factors of H. pylori infection, (ii) ROME III of general gastrointestinal symptomatology, and 
(iii) dyspepsia symptoms. Infected patients were treated with triple antibiotic therapy as 
previously described16,17. 
 
Patients attended the clinical facilities of the Universidad Peruana Cayetano Heredia Hospital in 
Metropolitan Lima. Under sedation, six gastric biopsies were obtained. Samples were taken 
preferentially from the body and antrum of the stomach and always from areas where the most 
inflammation was present. In the end, half of the biopsies were usually from the antrum and the 
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other half from the body. We used only one sample from the body and one from the antrum to 
perform the molecular analysis and culture. The remaining samples were used to perform the 
histopathological analysis and diagnosis. Research samples were suspended in 1.5 ml of 1x 
phosphate buffered saline (PBS) with 20% glycerol and frozen at –80 °C until analysis. 
 
Based on our experience in the SWOG/Gates Foundation study of 1,400 patients in seven sites of 
Latin America, patients were treated with a 14-day triple-standard regimen consisting of twice a 
day esomeprazole (instead of omeprazole), clarithromycin, and amoxicillin16,17. Treatment was 
provided free of charge to indigent patients. The response to therapy was assessed by the urea 
breath test (UBT) at 6-8 weeks, and those who did not respond to initial treatment received 
second- line treatment consisting of tetracycline, furazolidone, bismuth subsalicylate, and 
pantoprazole. All were evaluated at one year. H. pylori isolates from patients who did not 
respond at 6-8 weeks were tested for susceptibility to amoxicillin, clarithromycin, levofloxacin, 
metronidazole, rifampicin, and tetracycline using E-test strips from BioMerieux, France, and 
following the manufacturers’ recommendations. Results were interpreted as per the European 
Committee on Antimicrobial Susceptibility Testing18. 
 
Drinking water and biofilms 
The drinking water of gastric biopsy positive patients for H. pylori infection was sampled 
utilizing autoclaved bottles with sodium thiosulfate and sterile sponge swabs. Biofilm samples 
were collected from the inside of household faucets with swabs. This approach to obtain biofilms 
has been successful in our laboratory. Two two-liter aliquots of drinking water were sampled 
from household faucets after the water ran for at least one minute to assure the water collected 
 107 
was more representative of drinking water from the distribution system rather than water that had 
been sitting in the pipes. Water quality parameters including pH, temperature, dissolved oxygen, 
turbidity, conductivity, and free available chlorine were monitored using a water meter. Samples 
were handled as per the US Geological Society guidelines19. The two-liter aliquots of collected 
water were concentrated onto 0.22 µm membranes using vacuum filtration. One set of 
membranes and the biofilm samples were stored at –80 °C until processed. The other set of 
membranes were plated immediately on selective media for H. pylori culture in Lima using the 
technique of Degnan, et al.20.  
 
Briefly, special peptone, beef extract, yeast extract, sodium chloride (NaCl), phenol red (100 
mg), and agar were dissolved in sterile water and autoclaved for 20 minutes at 121 °C. After 
tempering the mixture to 50 °C, calf serum with iron (7%), antibiotics (7.5 mg/l amphotericin B, 
10 mg vancomycin, 5 mg trimethoprim, 5 mg cefsulodin, 3,500 U/L polymyxin B), and 600 
mg/L of urea were added, followed by a drop-wise addition of 0.8 ml of 1 N hydrochloric acid. 
Water samples were concentrated onto 0.22 µ membranes and placed aseptically onto the plates. 
Plates were incubated in anaerobic jars with Campylobacter GasPaks™ for seven days at 37 °C. 
All samples requiring molecular analysis for H. pylori were blinded and shipped to the 
University of Michigan for processing and analysis by PCR. 
 
Biofilm and water sample processing 
Membranes with concentrated water samples were scraped in 1 x PBS buffer with 0.2% Tween® 
20. Biofilm samples were wrung out in three sequential 10 ml aliquots of the same buffer. 
Tween® 20 was incorporated into the 1 x PBS solution to help remove cells and particulate 
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matter from the membranes and biofilm sponges. Suspensions were centrifuged, pelleted, and 
transferred to 1.5 ml Eppendorf tubes, where they were washed with 800 µl TE buffer. Samples 
were re-pelleted, the TE buffer removed, and samples were processed using the MoBio 
UltraClean™ Soil Kit (MO BIO Lab- oratories, Carlsbad, CA, USA), using the maximum yield 
alternative protocol. 
 
Biopsy sample processing 
Biopsy samples were homogenized using Omni Tip™ probes (OMNI International, Kennesaw, 
GA, USA). Following homogenization, biopsy samples were plated on Columbia Blood Agar 
(Oxoid, Altrincham, Cheshire, England) containing 10% defibrinated horse blood (Remel, 
Columbus, Ohio, USA), Dent supplement (Oxoid, Altrincham, Cheshire, England), and 3,500 
U/l polymyxin B. Plates were incubated at 37 °C for 3-7 days in microaerophilic conditions. 
Presumptive colonies were streaked onto 5% sheep blood Tryptic Soy Agar plates (Remel, 
Columbus, Ohio, USA) and confirmed as H. pylori with a rapid urease test and PCR. DNA 
extraction was performed using the Mastergram™ Gram Positive DNA Purification Kit 
(Epicentre, Charlotte, NC, USA). 
 
Histologic interpretation of gastric biopsies 
Biopsies were interpreted according to the histologic grading of gastritis by the Sidney 
System21,22. All patients had hematoxylin and eosin (H&E) stain as we do not routinely perform 
other stains such as a modified Giemsa or Warthin-Starry stain. Thus, the different levels of 
gastritis, whether acute, chronic, superficial, or deep, level of polymorphonuclear cells infiltrate, 
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H. pylori density, presence of lymphocyte follicles, intestinal metaplasia, dysplasia, or gastric 
atrophy were described. 
 
Urea breath test 
We used the kit of Kimberly-Clark PY Test 14C- Urea Breath Test. Results were reported as 
disintegrations per minute (DPM). Analysis for accuracy used the 10- minute breath sample. A 
breath sample DPM < 50 was defined as a negative result; DPM ≥ 200 was defined as a positive 
result; DPM in the range of 50-199 was classified as in- determinate. 
 
Quantitative polymerase chain reaction with HpF/HpR 
H. pylori in water, biofilm, and biopsy samples were quantified using a reaction mixture 
containing 10 µl 2 × SYBR® Green PCR Master Mix (Applied Biosystems, Grand Island, NY, 
USA), 0.4 µl of 20 µm primers (HpF: [gcgacctgctggaacattac] and HpR: [cgttagctgcattactggaga]), 
0.5-1 µl DNA template, and sterile H2O to bring the reaction volume to 20 µl. The standard 
curve comprised 101 to 106 cells H. pylori/µl. The quantitative PCR (qPCR) cycle included 
initial denaturation of target DNA at 95 °C for two minutes, followed by 45 cycles of 94 °C for 
one minute, 60 °C for one minute, and 72 °C for one minute to render a 138-bp product23. Efforts 
were put in place to assure the purity of the qPCR assay with melting curve analyses and the use 
of positive (H. pylori-positive samples) and negative controls (wells without H. pylori DNA 
added). All H. pylori-positive samples showed the same melting point as unknown positive 
samples. All negative controls were negative. Several H. pylori samples were sequenced and 
they always corresponded to H. pylori. No other sensitivity or specificity assays were performed. 
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Polymerase chain reaction with CagA and VacA 
Extracted DNA from biopsy samples was tested for the presence of H. pylori CagA and VacA 
genes by PCR using previously described primers and the TaKaRa PCR kit (Clontech, Mountain 
View, CA, USA). For CagA, previously described conditions and primers F1 (5 
'-GATAACAGGCAAGCTTTTGAGG 3) and B1 (5 CTGCAAAAGATTGTTTGGCAGA 3) 
were used to amplify a 349-base pair product24. Previously described primers VAG-F (5'-
CAATCTGTCCAATCAAGCGAG) and VAG-R (5-GCGTCAAAATAATTCCAAGG) were 
used under the following conditions to amplify the m1/m2 subunits of the VacA genes: initial 
denaturation at 95°C for two minutes followed by 35 cycles of 95 °C for one minute, 52 °C for 
one minute, 72°C for one minute, completed with a final extension at 72 °C for five minutes to 





Univariate linear regression models were used to evaluate linear associations between levels of 
H. pylori detected in a patient’s biopsy specimen and drinking water samples taken from the 
patient’s home, as measured by qPCR. Kruskal-Wallis tests were used to compare median levels 
of H. pylori detected in all three specimen types be- tween high-risk and low-risk patients. Chi-
square and Fisher’s exact tests were used to assess relationships between baseline biopsy results 
and patient characteristics. Data were further summarized using descriptive statistics and 
graphics. All analyses were conducted using R version 3.12 and SAS version 3. 
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This trial is registered with ClinicalTrials.gov, registration number NCT0151287, and SWOG 
clinical trial S1119. 
 
Results 
A total of 192 patients registered to the trial. Seven patients were excluded for the following 
reasons: three patients were breast-feeding at time of enrollment, two patients withdrew consent, 
and two patients were registered in error. Among the remaining 185 patients, 109 had H. pylori-
positive biopsies and were eligible and analyzable for treatment and water specimen studies.  
 
Seventy-six patients had negative biopsies and served as controls. Among the 109 patients with 
positive biopsies, 35% resided in low-risk districts and tested positive for H. pylori, compared to 
69.5% of those residing in high-risk districts (p = <0.0001) (Tables 4.1 and 4.2). Patient 
characteristics and district of residence are shown in tables 4.2 and 4.3, respectively. Most 
patients were female, had a normal or overweight body mass index (BMI) class, and were over 
the age year is shown in table 4.4. Among the patients who had a definitive UBT result at the 6-8 
week follow-up visit, 61 (66.3%) tested negative for H. pylori. Among the 31 patients who tested 
positive at 6-8 weeks, 23 (74.1%) responded to second-line therapy. Of the 31 patients positive at 
6-8 weeks after therapy, 18 tested negative at the one-year follow-up visit, 17 of them having 
completed second-line treatment. Among those with definitive results, including the 
administration of second-line therapy, the eradication rate at one year was 85%. Of the 12 
patients who tested positive at one year, 11 consented to undergo esophagogastroduodenoscopy 
and gastric biopsy; three of these patients’ biopsies yielded positive results. Five UBT-positive 
patients at one year were negative at 6-8 weeks, suggesting possible reinfection. 
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Thirteen of the 31 isolates from patients who did not respond to treatment at 6-8 weeks had 
studies of in vitro antibiotic sensitivity and two thirds demonstrated resistance to amoxicillin 
(69.2%), levofloxacin (69.2%), and metronidazole (61.5%). Resistance was less common to 
clarithromycin (15.4%), tetracycline (7.7%), and rifampicin (38.5%). The minimum inhibitory 
concentrations (MIC50, MIC90 and ranges) of the resistant strains were as follows in table 4.5. 
Gastric biopsy findings in biopsy positive patients were as follows: 99 (96%) had superficial 
chronic gastritis, 54 (53%) had deep or profound chronic gastritis, 93 (90%) had mucinous 
changes of the gastric mucosa, 91 (84%) had polymorphonuclear leukocytosis, 19 (18%) had 
intestinal metaplasia, and seven (6%) had gastric atrophy. The density of H. pylori present was 
described as large in 35%, moderate in 45%, and few in 19%. 
 
A summary of specimen data by source of origin is shown in table 4.6. The qPCR results were 
available for 109 biopsy specimens, 87 filtered water, and 50 biofilm samples. Additionally, 
residual chlorine content data was available for 83 filtered water samples. 
 
Sixty-one of 76 negative gastric biopsy samples were positive by qPCR (80.3%), with median 
123.4 (range, 1.9-538,322) CN/mg tissue. Of 109 positive gastric biopsy samples, 106 were 
positive by qPCR (97.2%), with median 46,914.3 (range, 5.1- 1,798,528.1) CN/mg tissue. Forty-
two of 87 filtered water specimens were positive by qPCR (48.3%), with median 931.5 (range 
8.5-1,682,500) CN/mg. Eighteen of 50 biofilm samples were positive by qPCR (36%), with 
median 1,654 (range, 24-68,600) CN/mg. Thus, the highest concentrations of qPCR H. pylori 
were measured in gastric biopsies and in the filtered water specimens. Residual chlorine was 
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measured in 80 of 83 filtered water samples (96.3%), with median 0.7 (range, 0.1-1.25) mg/L 
(Fig. 4.1). 
 
The physical properties of the filtered drinking water specimens were as follows: median pH 7.0 
(range, 6.5-8.5); median conductivity 53.2 µmhos (microohms per centimeter; range, 40-939); 
median Celsius temperature 22.6 (range, 18.8-27.4) and median turbidity 0.1 NTU 
(nephelometric turbidity unit; range, 0.0-27.4). There was no evidence of an association between 
the levels of H. pylori detected by qPCR in a patient’s gastric biopsy and the patient’s drinking 
water, for both filtered water and biofilm specimen. 
 
Furthermore, there was no evidence that the level of H. pylori detected in the gastric biopsies of 
biopsy positive patients differed by gastric cancer risk of patient’s district. Finally, no significant 
correlations were found between the level of H. pylori detected by qPCR in baseline gastric 
biopsy and response to treatment at 6-8 weeks and at one year. Out of the 109 eligible patients 
with H. pylori-positive gastric biopsies, 71 tested positive for CagA (65%), 78 tested positive for 
VacA (72%), and 15 (14%) tested positive for both. There was no evidence of an association 
between these results and clinical response at 6-8 weeks or at one year. 
 
Attempts to culture H. pylori from patient’s drinking water samples and from four samples taken 
from the main water plant in Lima (La Atarjea) were unsuccessful. However, all four La Atarjea 
samples, including two samples from the river intake (Rímac River) and two from two different 
reservoirs of treated water ready for public consumption, tested positive by qPCR: 1378.34, 
2520.00, 3275.00, and 3388.00 CN/L, respectively. 
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Information regarding primary water source for various domestic uses was obtained by patient 
survey for 74 H. pylori biopsy negative and 109 H. pylori biopsy positive patients. Most patients 
(95%) reported having interior plumbing and consuming water derived from the public system. 
For all intended uses surveyed, there were no differences between H. pylori-negative and -
positive patients with regards to primary water source. 
 
Patient-reported symptoms as measured by the Rome III questionnaire were similar for biopsy 
positive and biopsy negative patients. The percent of patients reporting symptoms of primary 
interest were: chronic dyspepsia (73%), chronic heartburn (35.1%), chronic postprandial distress 




In a part of the world where gastric carcinoma is the most common form of cancer and cause of 
cancer death4, the finding of H. pylori-specific DNA in the drinking water is significant. Fifty 
percent of water samples from homes of H. pylori-infected patients in this study showed 
evidence of H. pylori-specific DNA. Due to difficulties culturing H. pylori from water, we were 
unable to obtain any positive H. pylori isolates from water in Lima. The reasons for our inability 
to culture H. pylori from drinking water are multiple, including technical difficulties and the 
possibility that H. pylori might be present in its coccoid form that is harder to culture26.  
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H. pylori rapidly changes morphology from a spiral bacillus to a coccoid form in water, entering 
a viable but non-culturable state that makes it challenging to culture26,27. Historically, this 
conversion has raised doubts about whether H. pylori is viable and infectious in water. However, 
several independent studies have isolated and cultured H. pylori in wastewater and drinking 
water28–31and H. pylori has also been reliably detected in recreational and drinking water using 
molecular biology techniques29,32. Finally, the viable but non-culturable form of H. pylori has 
been shown to be infectious in mice via gavage33 and we previously showed that waterborne H. 
pylori is infectious in mice as well34. In addition to being culturable from water, there is evidence 
that H. pylori can survive or propagate in water in biofilms, extracellular structures that protect 
bacteria from chlorine, antibiotics, and other features of inhospitable environments, suggesting a 
mechanism by which H. pylori could shed into and contaminate water26,35. 
 
Our hypothesis that the drinking water of Lima is contaminated by H. pylori is corroborated by 
the large quantities of H. pylori we detected in water samples. Some of these quantities are 
higher than doses required for experimental human infection (ranging from 104 to 1010 
CFU/dose)36 and are similar to findings in recreational waters37,38. A recent risk assessment 
suggested that the maximum contaminant level goal for H. pylori be set at < 1 organism/l based 
on quantities of H. pylori in recreational water, a finding that our current study supports39ry. 
 
Our observations could be challenged because we were unable to culture H. pylori from drinking 
water in Lima. It could be argued that the presence of H. pylori-specific DNA in water does not 
prove the viability of H. pylori. However, the identification of H. pylori-specific DNA in the 
treated water of the water plant and in the homes of patients who are infected with H. pylori, 
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coupled with the observed reinfection after therapy and the frequency of gastric cancer in Lima, 
reinforce the validity of our findings. We may have detected the non-culturable but viable 
coccoid form of H. pylori in water. As discussed earlier, the infectious viability of this form of 
H. pylori has been demonstrated in mice33. The higher detection of H. pylori-specific DNA in 
drinking water of infected patients relative to values found in the main water plant may also 
reflect an additional contamination factor associated with the water irrigation system in Lima. 
However, our assertion is limited by our inability to culture H. pylori in water and the lack of 
corresponding fingerprinting for comparison between the H. pylori strains present in the water of 
the water plant, the H. pylori present in the water in patient’s homes, and the H. pylori present in 
their gastric mucosa. 
 
Gastric biopsies were interpreted according to the histologic grading of gastritis by the Sidney 
System21,22 and by H&E stain. Most patients had dif- ferent forms of either superficial (96%) or 
deep forms of chronic gastritis (53%) with mucinous changes of the gastric mucosa (90%). 
Intestinal metaplasia (18%) and gastric atrophy (6%) were less common. Even though some 
would argue that we should have used histochemical stains, such as a modified Giemsa stain or 
the Warthin-Starry stain, to enhance the detection of H. pylori in gastric biopsies, the review by 
Yantiss, et al. concludes that H. pylori is usually detectable in H&E- stained sections and that 
most ancillary stains show comparably high sensitivities (> 90%) for its detection40. 
 
In contrast to our previous report on the efficacy of triple therapy for H. pylori infection in Latin 
America, where a response of over 80% was observed, our response of less than 70% in this pilot 
study in Lima, Peru, raises concern16,17. Patients who did not respond to initial therapy responded 
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favorably to second-line therapy (71.8%). We identified antibiotic resistance to amoxicillin, 
levofloxacin, and metronidazole in two-thirds of H. pylori strains of patients who did not respond 
at 6-8 weeks from treatment. We also identified five patients who became positive at one year 
after being negative at 6-8 weeks, suggesting the possibility of H. pylori reinfection. Findings of 
resistance and reinfection would support the failure rate of 15% (12/80 patients) at one year that, 
when combined with the 12 patients who had inconclusive UBT results, would make the failure 
rate 26% (24/92 patients). Ramirez-Ramos, et al. had previously reported a failure rate of 73% at 
eight months after successful treatment for H. pylori infection in Lima15. Soto, et al. reported a 
30% recurrence rate at 18 months after successful treatment of H. pylori infection in Lima as 
well8. Soto further reported that, utilizing randomly amplified polymorphic DNA patterns and 
DNA sequence methodology, most of the episodes of recurrence observed represented 
reinfection. 
 
By PCR, we identified the presence of H. pylori in patient’s baseline gastric biopsy at a 
significantly higher rate in high-risk versus low-risk districts (p < 0.0001), likely the result of the 
presence and virulence of the H. pylori strain. The evidence of H. pylori in symptomatic patients 
with negative gastric biopsy for H. pylori infection raises the possibility of sub-clinical H. pylori 
infection, previously suspected in Spain41. We assured there was no evidence of contamination 
and ran the appropriate controls in these patients. As a result, one wonders if the use of enhanced 
narrow band imaging technology can uncover lesions induced by H. pylori in symptomatic 
patients who have negative biopsies. This technology has proven beneficial and superior to 
white-light imaging in recognizing the microvascular and mucosal surface pattern of patients 
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with depressed-type early gastric carcinoma lesions in Japan. This common form of gastric 
cancers in turn would be subject to limited endoscopic curative resections42. 
Neither the presence of pathogenicity markers such as CagA and VacA, nor the physical charac- 
teristics of the drinking water and the observations derived from the Rome III questionnaire 
demonstrated significance in this study. 
 
This study suggests that the drinking water of Metropolitan Lima is contaminated with H. pylori. 
The clinical and epidemiologic implications of this finding are significant not only for Lima, but 
for other cities of Peru and areas where H. pylori and gastric cancer are frequent such as Latin 
America, Asia, and Eastern Europe. Improvements in the technology of drinking water 
preparation and its distribution system could result in an effective primary prevention strategy of 
H. pylori infection and gastric carcinoma that will be more effective than massive antibiotic 
therapy of infected patients. 
 
In Japan, for example, improvements in sanitary conditions and eradication of H. pylori infection 
have reduced the incidence of gastric cancer by one-third43. However, these measures and 
massive screening have their limitations to the point of some advocating moving from secondary 
prevention to primary prevention of H. pylori infection and gastric cancer44. The findings of this 
study support that strategy. 
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Table 6.1. Participants 
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Table 0.1. Study participants and distribution of patients by risk district.  
Table 6.2. Characteristics of eligible patients 
 
Table 0.2. Characteristics of eligible patients.  
Table 6.3. H. pylori-positive findings by patient’s district risk 
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Table 0.3. H. pylori-positive findings by patient’s district risk 
Table 6.4. Treatment results by urea breath test at 6-8 weeks and at one year 
 
Table 0.4. Includes patients receiving second-line therapy 
Table 6.5. Antibiotic resistance information on 13 patients who did not respond to initial 
antibiotic treatment.  
 
Table 0.5. One value was >0.125 MIC: minimum inhibitory concentration. 




Table 0.6. CL: chlorine, qPCR: quantitative polymerase chain reaction 
 
 
Figure 0.1. Relationship between quantitative polymerase chain reaction in filtered drinking water and residual chlorine. No 
significant correlations were seen. 
 
 
 
 
